<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430165</article-id><article-id pub-id-type="pmcid-ver">PMC12430165.1</article-id><article-id pub-id-type="pmcaid">12430165</article-id><article-id pub-id-type="pmcaiid">12430165</article-id><article-id pub-id-type="doi">10.3390/nu17172752</article-id><article-id pub-id-type="publisher-id">nutrients-17-02752</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Scientific and Public Health Challenges in Folic Acid Supplementation: Insights from Brazil and Global Implications</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4093-4583</contrib-id><name name-style="western"><surname>Rockenbach</surname><given-names initials="MK">Mar&#237;lia K&#246;rbes</given-names></name><xref rid="af1-nutrients-17-02752" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02752" ref-type="aff">2</xref><xref rid="af3-nutrients-17-02752" ref-type="aff">3</xref><xref rid="c1-nutrients-17-02752" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5297-5916</contrib-id><name name-style="western"><surname>Rohweder</surname><given-names initials="R">Ricardo</given-names></name><xref rid="af1-nutrients-17-02752" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02752" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2428-0460</contrib-id><name name-style="western"><surname>Schuler-Faccini</surname><given-names initials="L">Lavinia</given-names></name><xref rid="af1-nutrients-17-02752" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02752" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7404-2911</contrib-id><name name-style="western"><surname>Sanseverino</surname><given-names initials="MTV">Maria Teresa Vieira</given-names></name><xref rid="af1-nutrients-17-02752" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02752" ref-type="aff">2</xref><xref rid="af4-nutrients-17-02752" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5799-2272</contrib-id><name name-style="western"><surname>Kowalski</surname><given-names initials="TW">Thayne Woycinck</given-names></name><xref rid="af1-nutrients-17-02752" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02752" ref-type="aff">2</xref><xref rid="af3-nutrients-17-02752" ref-type="aff">3</xref><xref rid="c1-nutrients-17-02752" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Bhutta</surname><given-names initials="ZA">Zulfiqar A.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Black</surname><given-names initials="RE">Robert E.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name name-style="western"><surname>Hurley</surname><given-names initials="KM">Kristen M.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02752"><label>1</label>Graduate Program in Genetics and Molecular Biology (PPGBM), Genetics Department, Universidade Federal do Rio Grande do Sul, Porto Alegre 91501-970, Brazil; <email>ricardo.rohweder@ufrgs.br</email> (R.R.); <email>lschuler@hcpa.edu.br</email> (L.S.-F.); <email>msanseverino@hcpa.edu.br</email> (M.T.V.S.)</aff><aff id="af2-nutrients-17-02752"><label>2</label>Teratogen Information System (SIAT), Medical Genetics Service (SGM), Hospital de Cl&#237;nicas de Porto Alegre, Porto Alegre 90035-903, Brazil</aff><aff id="af3-nutrients-17-02752"><label>3</label>Laboratory of Genomic Medicine (LMG), Center of Experimental Research, Hospital de Cl&#237;nicas de Porto Alegre, Porto Alegre 90035-903, Brazil</aff><aff id="af4-nutrients-17-02752"><label>4</label>Medical School, Pontif&#237;cia Universidade Cat&#243;lica do Rio Grande do Sul (PUCRS), Porto Alegre 90619-900, Brazil</aff><author-notes><corresp id="c1-nutrients-17-02752"><label>*</label>Correspondence: <email>mkrockenbach@hcpa.edu.br</email> (M.K.R.); <email>tkowalski@hcpa.edu.br</email> (T.W.K.)</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2752</elocation-id><history><date date-type="received"><day>24</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>17</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02752.pdf"/><abstract><p>Folic acid supplementation during the periconceptional period is a well-established strategy to prevent neural tube defects (NTDs). However, emerging uncertainties surrounding optimal dosage, alternative folate forms, duration of use, and the role of genetic variability have sparked scientific and policy debates. In Brazil, these challenges are amplified by unique contextual factors, including the routine distribution of high-dose folic acid (5000 &#181;g) through the public health system, social vulnerability, low adherence, and limited population-specific evidence for the country&#8217;s highly admixed population. This narrative review critically examined the scientific evidence and public health policies surrounding folic acid supplementation, with a focus on Brazil. We examined historical developments, international recommendations, and emerging controversies, including the emerging influence of misinformation. Despite the worldwide progress in NTD prevention, both local and global challenges persist, including delayed initiation, inconsistent adherence, and uncertainty regarding alternative supplementation regimens. Addressing these demands requires the development of context-specific guidelines, alongside coordinated strategies in provider training, public education, monitoring, and research investments to ensure effective, safe, and equitable folic acid supplementation.</p></abstract><kwd-group><kwd>folate</kwd><kwd>5-methyltetrahydrofolate</kwd><kwd>dose</kwd><kwd>pregnancy</kwd><kwd>health inequalities</kwd></kwd-group><funding-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq)</funding-source><funding-source>Departamento de Ci&#234;ncia e Tecnologia da Secretaria de Ci&#234;ncia</funding-source><award-id>445345/2023-3</award-id></award-group><award-group><funding-source>Hospital de Cl&#237;nicas de Porto Alegre (HCPA)</funding-source><funding-source>Fundo de Incentivo &#224; Pesquisa e Eventos (FIPE)</funding-source><award-id>2024-0154</award-id></award-group><award-group><funding-source>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado do Rio Grande do Sul (Fapergs)</funding-source><award-id>24/2551-0000690-7</award-id></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq)</funding-source><award-id>149066/2022-8</award-id></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq)</funding-source><award-id>150181/2023-0</award-id></award-group><award-group><funding-source>Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES)</funding-source><award-id>88887.893905/2023-00</award-id></award-group><funding-statement>This research was funded by the Conselho Nacional de Desenvolvimento Cient&#237;fico e Tecnol&#243;gico (CNPq) and Departamento de Ci&#234;ncia e Tecnologia da Secretaria de Ci&#234;ncia, Tecnologia e Inova&#231;&#227;o e do Complexo Econ&#244;mico-Industrial da Sa&#250;de do Minist&#233;rio da Sa&#250;de (Decit/Sectics/MS), grant number 445345/2023-3; Hospital de Cl&#237;nicas de Porto Alegre (HCPA), Fundo de Incentivo &#224; Pesquisa e Eventos (FIPE), grant number 2024-0154; Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado do Rio Grande do Sul (Fapergs), grant number 24/2551-0000690-7. The scholarships of the authors were funded by CNPq&#8212;R.R. 149066/2022-8 and T.W.K. 150181/2023-0&#8212;and Coordena&#231;&#227;o de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior (CAPES)&#8212;M.K.R. 88887.893905/2023-00.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02752"><title>1. Introduction</title><p>Maternal nutrition plays a crucial role in ensuring a healthy pregnancy, supporting both periconceptional health and optimal fetal development, and promoting long-term health outcomes for both mother and child [<xref rid="B1-nutrients-17-02752" ref-type="bibr">1</xref>]. Among nutritional factors, folate deficiency during the periconceptional period is strongly associated with an increased risk of congenital anomalies, especially neural tube defects (NTDs) [<xref rid="B2-nutrients-17-02752" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-17-02752" ref-type="bibr">3</xref>]. The periconceptional period refers to the time surrounding conception; although its exact duration may vary according to the study and context, it is usually defined as the 14 weeks before and 10 weeks after conception, encompassing gametogenesis, fertilization, and early embryonic and placental development [<xref rid="B4-nutrients-17-02752" ref-type="bibr">4</xref>]. NTDs result from the failure of neural tube closure during early embryogenesis (between 17 and 28 days post-conception), leading to significant morbidity and mortality, depending on the location and severity of the lesion [<xref rid="B5-nutrients-17-02752" ref-type="bibr">5</xref>]. The specific type of NTD reflects the site of disrupted neurulation. This could range from the most severe form, craniorachischisis, involving the failure of neural tube closure at the initial site, resulting in an open brain and spinal cord, to less severe forms such as spina bifida, caused by incomplete closure of the caudal neural tube [<xref rid="B5-nutrients-17-02752" ref-type="bibr">5</xref>].</p><p>Most NTDs have a multifactorial etiology [<xref rid="B6-nutrients-17-02752" ref-type="bibr">6</xref>], with maternal folate status representing the principal modifiable environmental determinant risk [<xref rid="B7-nutrients-17-02752" ref-type="bibr">7</xref>]. Folate, a water-soluble B9 vitamin, is naturally present in foods such as green leafy vegetables and meats and plays a critical role in DNA and RNA synthesis, as well as in DNA methylation, which are fundamental to embryonic development [<xref rid="B8-nutrients-17-02752" ref-type="bibr">8</xref>]. During pregnancy, the demand for folate increases significantly to support the intense proliferation and differentiation of fetal cells [<xref rid="B9-nutrients-17-02752" ref-type="bibr">9</xref>]. Given its critical role, folic acid, the synthetic form of folate, has been recommended globally for women of reproductive age. Many countries are adopting mandatory and/or voluntary folic acid fortification policies [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>,<xref rid="B11-nutrients-17-02752" ref-type="bibr">11</xref>], which has significantly contributed to reductions in NTD prevalence worldwide [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>,<xref rid="B12-nutrients-17-02752" ref-type="bibr">12</xref>].</p><p>The United States and Canada were the first countries to mandate folic acid fortification in 1996 and 1998, respectively, followed by several Central and South American countries in the late 1990s and 2000s, and by Australia in 2009. The European Union and China introduced voluntary fortification in 2006 and 2012, respectively. A systematic review reported that mean plasma folate concentrations increased from 18.2 to 33.9 nmol/L in the Americas and Australia after mandatory fortification, from 15.2 to 21.4 nmol/L in Europe following voluntary fortification, and from 13.2 to 20.1 nmol/L in China [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>]. The same review also showed that the mean prevalence of NTDs per 10,000 births was 4.19 in populations with mandatory fortification, 7.61 in those with voluntary fortification, and 9.66 in populations without fortification [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>], underscoring the public health impact of fortification policies.</p><p>However, the widespread use of both supplementation and fortification, often without coordinated public health monitoring, has led to the emergence of new concerns. These include potential adverse effects of excessive folate intake, such as possible masking of vitamin B12 deficiency, increased susceptibility to gestational diabetes mellitus, and associations with certain types of cancer [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. Although these concerns warrant attention, the evidence remains limited and inconclusive. Scientific debates have intensified regarding the optimal dosage and duration of supplementation, particularly beyond the first trimester [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-17-02752" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-17-02752" ref-type="bibr">15</xref>], as well as the potential benefits of alternative folate forms, such as 5-methyltetrahydrofolate (5-MTHF), especially in individuals with genetic polymorphisms that impair folic acid metabolism [<xref rid="B16-nutrients-17-02752" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-17-02752" ref-type="bibr">17</xref>]. While these discussions are valuable for advancing knowledge, their communication to the public is sometimes concerning. Sensationalist headlines and oversimplified interpretations fuel misinformation. Claims that high folate levels cause autism spectrum disorder or that 5-MTHF is superior to folic acid, despite a dearth of robust evidence, may reduce adherence to evidence-based supplementation guidelines.</p><p>In low- and middle-income countries like Brazil, these concerns are amplified by social vulnerability, with lower education levels and social minority groups particularly at risk of health misinformation [<xref rid="B18-nutrients-17-02752" ref-type="bibr">18</xref>]. Socioeconomic inequalities and limited access to reproductive health information further complicate adherence and timely initiation of supplementation [<xref rid="B19-nutrients-17-02752" ref-type="bibr">19</xref>,<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>]. Furthermore, Brazil faces specific concerns regarding dosage, as the country&#8217;s Unified Health System (SUS&#8212;Sistema &#218;nico de Sa&#250;de) currently provides folic acid in 5000 &#181;g tablets, more than ten times the internationally recommended daily dose of 400 &#181;g for NTD prevention [<xref rid="B11-nutrients-17-02752" ref-type="bibr">11</xref>]. Brazil&#8217;s unique genetic diversity also raises important questions about the applicability of current international guidelines. These recommendations were derived from early clinical trials conducted among European and North American populations [<xref rid="B21-nutrients-17-02752" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>], which may not accurately reflect the metabolic and clinical responses of the Brazilian population. Together, these factors underscore the need for context-specific public health policies, more personalized dosing strategies, and evidence-based interventions adapted to Brazilian settings.</p><p>In light of these challenges, this paper aims to discuss current scientific and policy controversies surrounding folic acid supplementation, focusing on the Brazilian context. We begin with a brief historical overview and current international recommendations on folic acid use, followed by a discussion of emerging controversies and concerns related to folic acid exposure. Next, we examine Brazil&#8217;s unique challenges, including issues related to dosage, access, adherence, and genetic diversity. Finally, we propose future directions and outline short- and long-term strategies to improve the safety, effectiveness, and equity of folic acid supplementation policies. While grounded in the Brazilian context, the insights presented here may also be relevant to other low- and middle-income countries facing similar structural and population-specific barriers.</p></sec><sec id="sec2-nutrients-17-02752"><title>2. History and Current Recommendations for Folic Acid Use</title><p>Folate has been associated with reproduction as early as 1965, due to its involvement in cellular proliferation and tissue growth [<xref rid="B24-nutrients-17-02752" ref-type="bibr">24</xref>]. In 1976, Smithells et al. hypothesized that undernutrition could be a common environmental factor contributing to the occurrence of NTDs [<xref rid="B25-nutrients-17-02752" ref-type="bibr">25</xref>], prompting a series of studies on vitamin supplementation during pregnancy [<xref rid="B26-nutrients-17-02752" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02752" ref-type="bibr">27</xref>,<xref rid="B28-nutrients-17-02752" ref-type="bibr">28</xref>]. Subsequent research demonstrated that among the vitamins included in the multivitamin supplements, folic acid was the key component responsible for reducing the risk of NTDs [<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>]. Neural tube closure relies on complex biological processes, including convergent extension of the neural plate, neural crest cell migration, and neuroepithelial apoptosis, proliferation, and differentiation. Folate deficiency has been linked to DNA hypomethylation, impaired nucleotide synthesis, and genomic instability, mechanisms that may contribute to the development of NTDs [<xref rid="B29-nutrients-17-02752" ref-type="bibr">29</xref>].</p><p>The first randomized clinical trial (RCT) demonstrating that folic acid supplementation around the time of conception reduces the risk of NTDs was conducted in South Wales [<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>]. In 1991, a larger RCT including seven countries (England, Hungary, Israel, Australia, Canada, Russia, and France) reported a 72% reduction in NTD recurrence with daily supplementation of 4000 micrograms (&#181;g) of folic acid [<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>]. These results led the Centers for Disease Control and Prevention (CDC) to recommend folic acid supplementation for all women of childbearing age with a previous history of NTDs [<xref rid="B30-nutrients-17-02752" ref-type="bibr">30</xref>]. The following year, a Hungarian RCT demonstrated that periconceptional supplementation with a multivitamin containing 800 &#181;g of folic acid reduced the first occurrence of NTDs [<xref rid="B21-nutrients-17-02752" ref-type="bibr">21</xref>]. Together, these findings prompted the expansion of public health recommendations to include folic acid supplementation for all women of reproductive age [<xref rid="B11-nutrients-17-02752" ref-type="bibr">11</xref>,<xref rid="B31-nutrients-17-02752" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-17-02752" ref-type="bibr">32</xref>].</p><p>Current recommendations for folic acid supplementation to prevent NTDs are still based on the initial studies conducted in the 1980s and 1990s. Both the CDC and the World Health Organization (WHO) recommend a daily intake of 400 &#181;g of folic acid, starting before conception and continuing through the first 12 weeks of gestation [<xref rid="B31-nutrients-17-02752" ref-type="bibr">31</xref>,<xref rid="B33-nutrients-17-02752" ref-type="bibr">33</xref>]. Women at high risk for NTDs, such as those with a history of an NTD-affected pregnancy or using antifolate medications, are advised a higher dose of 4000 &#181;g per day [<xref rid="B31-nutrients-17-02752" ref-type="bibr">31</xref>]. Since the optimal dose for preventing NTDs has never been thoroughly investigated, these agencies continue to base their guidelines on the doses used in the earliest studies: 360 &#181;g [<xref rid="B26-nutrients-17-02752" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02752" ref-type="bibr">27</xref>,<xref rid="B28-nutrients-17-02752" ref-type="bibr">28</xref>], 800 &#181;g [<xref rid="B21-nutrients-17-02752" ref-type="bibr">21</xref>], and 4000 &#181;g for women with previous NTD-affected pregnancy [<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>]. Consequently, guidelines vary in both recommended doses and supplementation duration, as reviewed by Cawley et al. for 20 European countries [<xref rid="B34-nutrients-17-02752" ref-type="bibr">34</xref>] and as summarized in <xref rid="nutrients-17-02752-t001" ref-type="table">Table 1</xref>. This range of doses reflects the fact that the early studies used the formulations available at the time, which differed in folic acid content, and that higher doses were specifically tested for women at high risk of recurrence.</p><p>In the years following the initial recommendations, the expected decline in NTD prevalence was not observed [<xref rid="B35-nutrients-17-02752" ref-type="bibr">35</xref>]. This was largely attributed to the high rate of unplanned pregnancies [<xref rid="B36-nutrients-17-02752" ref-type="bibr">36</xref>], which caused many women to miss the critical window for supplementation, as neural tube closure occurs very early in embryonic development. Additionally, factors such as low levels of formal education, immigrant status, young maternal age, and absence of a partner were identified as predictors of reduced periconceptional folic acid use [<xref rid="B37-nutrients-17-02752" ref-type="bibr">37</xref>], highlighting how interventions that rely on individual lifestyle modifications are subject to socioeconomic disparities. In response to these challenges, and from a broader public health perspective, many countries have implemented mandatory folic acid food fortification programs as a population-wide preventive strategy [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>].</p><p>As of July 2023, 69 countries globally have implemented mandatory folic acid fortification [<xref rid="B10-nutrients-17-02752" ref-type="bibr">10</xref>], including Brazil. The impact of these programs on NTD prevalence varies across countries. A meta-analysis across five countries (Canada, USA, Chile, Argentina, and South Africa) estimated a 46% reduction in NTD risk following the implementation of mandatory folic acid fortification [<xref rid="B38-nutrients-17-02752" ref-type="bibr">38</xref>]. Beyond NTD prevention, folic acid fortification has also been associated with reduced risks of congenital heart defects, nonsyndromic cleft lip and palate, anemia, cardiovascular disease, and certain types of cancer [<xref rid="B39-nutrients-17-02752" ref-type="bibr">39</xref>].</p><p>Nevertheless, fortification programs typically add only modest amounts of folic acid to staple foods (100&#8211;260 &#956;g per 100 g of product), resulting in an estimated daily intake of 200 &#181;g [<xref rid="B39-nutrients-17-02752" ref-type="bibr">39</xref>], which is below the 400 &#181;g/day recommended by the CDC for periconceptional supplementation [<xref rid="B31-nutrients-17-02752" ref-type="bibr">31</xref>]. Therefore, even in countries with mandatory fortification policies, daily supplementation with 400 &#181;g of folic acid is still advised for women of reproductive age. It must be emphasized that folate adequacy for preventing NTDs is critical in the first four weeks of gestation, as neural tube closure is around 28 days post-conception. However, as demonstrated in <xref rid="nutrients-17-02752-t002" ref-type="table">Table 2</xref>, folic acid supplementation often does not occur within the optimal window for preventing NTDs. By the time we finished the literature review, there were no other studies evaluating folic acid supplementation in Brazil.</p><p>Despite the benefits of folic acid supplementation being documented, concerns have emerged regarding the potential adverse effects of high-dose intake, including cumulative exposure from both fortified foods and supplements [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. This issue is particularly relevant in countries like Brazil, where the public health system provides folic acid supplements at a dose of 5000 &#181;g, ten times higher than the standard recommended intake.</p></sec><sec id="sec3-nutrients-17-02752"><title>3. Current Debates and Emerging Concerns Regarding Folic Acid Supplementation</title><p>Folate deficiency is associated with a broad spectrum of adverse health outcomes beyond NTDs, including megaloblastic anemia, chronic diseases such as cardiovascular diseases, neuropsychiatric disorders, and cancer [<xref rid="B47-nutrients-17-02752" ref-type="bibr">47</xref>]. Conversely, excessive folate intake may also be linked to adverse effects [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. Given folate&#8217;s essential role in key biological processes, it is unsurprising that both deficiency and excess can result in a wide range of clinical manifestations. Poor folate status can lead to abnormalities in DNA and protein synthesis, post-translational modifications, and gene expression [<xref rid="B47-nutrients-17-02752" ref-type="bibr">47</xref>]. Conversely, excessive folate intake may also affect gene expression, DNA methylation patterns, uncontrolled cell growth and proliferation, modulation of inflammation and immune responses, and disruption of one-carbon metabolism [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>].</p><p>Unlike 5-MTHF (and natural folate), folic acid has an established upper tolerable limit (UL), set by the US Institute of Medicine at 1000 &#956;g/day. However, this limit was determined to prevent masking of vitamin B12 deficiency and was not based on folic acid bioavailability or metabolism [<xref rid="B32-nutrients-17-02752" ref-type="bibr">32</xref>]. Both folate and vitamin B12 deficiency can lead to megaloblastic anemia, a group of anemias characterized by abnormally large nucleated erythrocytes, caused by inhibited maturation of erythropoietic precursor cells [<xref rid="B47-nutrients-17-02752" ref-type="bibr">47</xref>]. In the 1940s, before the recognition that vitamin B12 deficiency causes pernicious anemia&#8212;a specific type of megaloblastic anemia&#8212;high-dose folic acid used for its treatment restored normal blood values but did not prevent the vitamin B12 deficiency-related neuropathy, delaying its diagnosis and leading to progressive neurological damage [<xref rid="B47-nutrients-17-02752" ref-type="bibr">47</xref>,<xref rid="B48-nutrients-17-02752" ref-type="bibr">48</xref>]. However, current medical practice does not rely on the presence of anemia for diagnosing vitamin B12 deficiency; instead, blood levels of vitamin B12 and related metabolites are directly measured [<xref rid="B47-nutrients-17-02752" ref-type="bibr">47</xref>]. Although some evidence suggests that folic acid may also exacerbate the neuropathological progression of vitamin B12 deficiency, the evidence is primarily correlative or from uncontrolled clinical observations [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. Nonetheless, increased vigilance for identifying vitamin B12 deficiency is important in at-risk patients, such as those with low vitamin B12 intake or conditions that are associated with vitamin B12 malabsorption, and who also ingest excessive folic acid [<xref rid="B48-nutrients-17-02752" ref-type="bibr">48</xref>].</p><p>When folic acid intake exceeds the body&#8217;s metabolic capacity, unmetabolized folic acid (UMFA) can accumulate in the bloodstream due to saturation of the enzymatic conversion to its biologically active form, 5-MTHF [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. Although no direct causal relationship has been established between elevated UMFA and adverse health outcomes, evidence suggests that UMFA may interfere with one-carbon metabolism by modulating the activity of enzymes involved in the folate cycle, potentially affecting DNA synthesis, repair, and methylation processes [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>].</p><p>The impact of excessive folic acid intake on human health remains inconclusive and sometimes contradictory [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>], as shown in <xref rid="nutrients-17-02752-t003" ref-type="table">Table 3</xref>. This suggests that both insufficient and excessive exposure to folic acid may carry potential health risks. A growing body of evidence associates folic acid excess with adverse health outcomes impacting cancer, immunity, birth outcomes, cardiovascular disease, and overall mortality [<xref rid="B13-nutrients-17-02752" ref-type="bibr">13</xref>]. A meta-analysis demonstrated that elevated serum and red blood cell folate concentrations are associated with a higher risk of developing gestational diabetes mellitus, with the effects varying depending on the timing and duration of supplementation [<xref rid="B49-nutrients-17-02752" ref-type="bibr">49</xref>]. This emphasizes the importance of considering both dose and exposure window when assessing folic acid safety. Findings from an Indian birth cohort, where pregnant women are often prescribed folic acid doses as high as 5000 &#181;g/day, showed that high maternal folate concentrations were associated with insulin resistance in children, suggesting disturbances in fetal metabolic programming, which could contribute to a higher risk of developing diabetes later in life [<xref rid="B50-nutrients-17-02752" ref-type="bibr">50</xref>]. Additionally, misinformation stemming from the misinterpretation of scientific data has led to claims linking high folate levels to autism spectrum disorder. However, there is no evidence of a causal relationship, and meta-analyses have demonstrated a potential protective effect of periconceptional folic acid supplementation in reducing the risk of autism spectrum disorder (ASD) [<xref rid="B51-nutrients-17-02752" ref-type="bibr">51</xref>,<xref rid="B52-nutrients-17-02752" ref-type="bibr">52</xref>]. Early pregnancy is a critical period for central nervous system development. Folate deficiency during this time may impair the proliferation and migration of neural progenitor cells by altering DNA methylation and gene expression, potentially increasing the risk of ASD [<xref rid="B53-nutrients-17-02752" ref-type="bibr">53</xref>].</p><p>Irrespective of the form, folate is converted to 5-MTHF, the predominant circulating form of folate in the blood [<xref rid="B61-nutrients-17-02752" ref-type="bibr">61</xref>]. This conversion can be less efficient in individuals carrying common genetic variants in the methylenetetrahydrofolate reductase (MTHFR) gene [<xref rid="B17-nutrients-17-02752" ref-type="bibr">17</xref>]. As a result, 5-MTHF has been proposed as a potential alternative to folic acid for individuals with <italic toggle="yes">MTHFR</italic> variants [<xref rid="B62-nutrients-17-02752" ref-type="bibr">62</xref>] and is now included in several commercial multivitamin products. However, there is currently no evidence supporting the effectiveness of 5-MTHF in preventing NTDs [<xref rid="B63-nutrients-17-02752" ref-type="bibr">63</xref>]. Moreover, the CDC does not recommend <italic toggle="yes">MTHFR</italic> genotyping for clinical decision-making and states that there is no demonstrated benefit of using 5-MTHF over folic acid [<xref rid="B64-nutrients-17-02752" ref-type="bibr">64</xref>].</p><p>Therefore, international public health guidelines recommend folic acid, not 5-MTHF supplementation for NTD prevention [<xref rid="B64-nutrients-17-02752" ref-type="bibr">64</xref>,<xref rid="B65-nutrients-17-02752" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-17-02752" ref-type="bibr">66</xref>]. Only a well-designed RCT directly comparing 5-MTHF and folic acid could definitively establish the efficacy of 5-MTHF for this purpose. In the meantime, the dissemination of misinformation about the superiority of 5-MTHF has led many individuals to spend substantial amounts on multivitamins containing this form, which is more expensive to manufacture than folic acid due to its lower chemical stability [<xref rid="B67-nutrients-17-02752" ref-type="bibr">67</xref>].</p><p>The optimal duration of folic acid supplementation beyond the first trimester, post-natally, and during breastfeeding remains unclear regarding its benefits to maternal and fetal health [<xref rid="B15-nutrients-17-02752" ref-type="bibr">15</xref>]. Recent studies have reported conflicting results regarding its prolonged usage. The Society of Obstetricians and Gynecologists of Canada (SOGC) recommends folic acid supplementation starting 2&#8211;3 months before conception and continuing until the end of lactation (or 4&#8211;6 weeks postpartum if not breastfeeding) [<xref rid="B68-nutrients-17-02752" ref-type="bibr">68</xref>]. Supporting this extended supplementation, a cohort study from Ireland found that continued intake of 400 &#181;g/day of folic acid during the second and third trimesters was associated with improved neurodevelopmental outcomes in children [<xref rid="B69-nutrients-17-02752" ref-type="bibr">69</xref>]. Conversely, other studies have raised concerns about possible associations between late-pregnancy folic acid exposure and an increased risk of allergic disorders in children [<xref rid="B70-nutrients-17-02752" ref-type="bibr">70</xref>]. A prospective study from China demonstrated that initiating folic acid supplementation 1.5 months before conception, with a duration of four months, is the preferred option for preventing congenital malformation [<xref rid="B71-nutrients-17-02752" ref-type="bibr">71</xref>]. Altogether, while evidence supports both extended and more limited durations of folic acid use, further studies are needed to clarify the long-term benefits and potential risks associated with supplementation beyond the first trimester.</p><p>Hence, while folate adequacy is essential in early gestation, the optimal duration, dosage, and long-term implications of supplementation warrant further investigation. Future research, including RCT comparing folic acid and 5-MTHF, different dosing regimens, and durations of use, is essential to guide evidence-based recommendations that maximize efficacy in NTD prevention while protecting overall maternal&#8211;child health. <xref rid="nutrients-17-02752-f001" ref-type="fig">Figure 1</xref> summarizes the evolution of folic acid supplementation, from early clinical trials to current guidelines and emerging challenges.</p><p>Although most of the available evidence and recommendations stem from high-income countries, the local context must also be considered. In Brazil, specific challenges related to the available formulations, health system policies, and socioeconomic disparities further complicate adherence to folic acid supplementation.</p></sec><sec id="sec4-nutrients-17-02752"><title>4. Specific Aspects of Folic Acid Supplementation in Lower-Income Countries: The Brazilian Example</title><p>Brazil is a vast and diverse country characterized by pronounced socioeconomic disparities and significant inequalities in health and nutrition [<xref rid="B72-nutrients-17-02752" ref-type="bibr">72</xref>]. Although the public health system, SUS, provides universal healthcare coverage and serves approximately 60% of the population, access to health services and health outcomes vary considerably across regions [<xref rid="B73-nutrients-17-02752" ref-type="bibr">73</xref>,<xref rid="B74-nutrients-17-02752" ref-type="bibr">74</xref>]. Populations with lower incomes and those residing in economically deprived areas are the most disadvantaged [<xref rid="B75-nutrients-17-02752" ref-type="bibr">75</xref>]. These inequalities also influence dietary patterns: consumption of fresh fruits and vegetables declines progressively from higher- to lower-income strata and is lower among Black individuals compared to White individuals [<xref rid="B76-nutrients-17-02752" ref-type="bibr">76</xref>], potentially limiting natural folate intake in these groups. Furthermore, adherence to folic acid supplementation is associated with maternal education and socioeconomic status [<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>,<xref rid="B77-nutrients-17-02752" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-17-02752" ref-type="bibr">78</xref>], underscoring how folate availability from both dietary and supplemental sources is shaped by regional, racial, social, and economic factors in Brazil.</p><p>Acquired folate deficiency is associated with reduced intake, chronic alcohol consumption, increased demands in pregnancy, and malabsorption [<xref rid="B2-nutrients-17-02752" ref-type="bibr">2</xref>]. These risk factors are often exacerbated in socioeconomically disadvantaged populations, where individuals may face limited access to a variety of nutrient-rich foods. In such environments, the lack of clean water, sanitation, and hygiene further increases the risk of diarrheal diseases [<xref rid="B79-nutrients-17-02752" ref-type="bibr">79</xref>], which can compromise the absorption of essential nutrients, including folate. Moreover, lower socioeconomic status is associated with greater alcohol-attributable health harm [<xref rid="B80-nutrients-17-02752" ref-type="bibr">80</xref>]. Therefore, these vulnerable populations are more likely to have inadequate folate levels, emphasizing the need for targeted public health policies to mitigate deficiencies and their broader health consequences.</p><p>Beyond these contextual disparities, current recommendations for folic acid supplementation are based on the early clinical trials conducted in European and North American populations [<xref rid="B21-nutrients-17-02752" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>]. Such guidelines may not fully reflect the reality of genetically admixed populations such as Brazil. A recent study has identified Brazilians as among the most genetically diverse populations worldwide, with a complex ancestry comprising European, African, and Indigenous contributions [<xref rid="B81-nutrients-17-02752" ref-type="bibr">81</xref>]. This diversity includes genetic variants that may influence nutrient metabolism and drug response [<xref rid="B81-nutrients-17-02752" ref-type="bibr">81</xref>]. Genetic polymorphisms or mutations in proteins involved in one-carbon metabolism (e.g., MTHFR) or folate transport (e.g., the reduced folate carrier) can modulate folate metabolism and increase susceptibility to folate-related diseases [<xref rid="B82-nutrients-17-02752" ref-type="bibr">82</xref>,<xref rid="B83-nutrients-17-02752" ref-type="bibr">83</xref>]. The frequency and distribution of these variants vary across populations and ethnic groups [<xref rid="B84-nutrients-17-02752" ref-type="bibr">84</xref>].</p><p>In admixed populations like Brazil, this genetic variability may lead to differences in individual responses to folic acid supplementation. For example, individuals carrying certain <italic toggle="yes">MTHFR</italic> polymorphisms may have reduced enzymatic activity, resulting in lower conversion of folate to its active forms [<xref rid="B82-nutrients-17-02752" ref-type="bibr">82</xref>]. Similarly, variants in folate transport proteins may influence cellular uptake, bioavailability, and tissue distribution of folate, affecting the risk of deficiency [<xref rid="B85-nutrients-17-02752" ref-type="bibr">85</xref>]. The unique genetic admixture of the Brazilian population, shaped by complex history and migration patterns, has revealed a significant proportion of previously unreported genetic variants [<xref rid="B84-nutrients-17-02752" ref-type="bibr">84</xref>], underscoring the importance of considering Brazil&#8217;s unique genetic profile when developing public health strategies, including those involving folic acid supplementation.</p><p>In response to the burden of NTDs, Brazil implemented a nationwide fortification policy in 2002, mandating the addition of folic acid to wheat and corn flours [<xref rid="B86-nutrients-17-02752" ref-type="bibr">86</xref>]. According to the current regulation established by the National Health Surveillance Agency, the required folic acid content ranges from 140 to 220 &#181;g per 100 g of product [<xref rid="B87-nutrients-17-02752" ref-type="bibr">87</xref>]. However, data from national flour fortification programs have shown that more than half of the products fail to meet the recommended levels. In 2021, 50% of the products analyzed exceeded the upper limit, while 12% fell below the minimum threshold [<xref rid="B88-nutrients-17-02752" ref-type="bibr">88</xref>]. Notwithstanding these challenges, the policy has been associated with a 30% reduction in NTD prevalence and a 22.8% decrease in related healthcare costs [<xref rid="B89-nutrients-17-02752" ref-type="bibr">89</xref>]. Notably, one study reported a comparatively lower effect of folic acid fortification on NTD prevention in Brazil relative to other Latin American countries, attributing this to factors such as Brazil&#8217;s unique ethnic composition, differences in dietary intake, and variability in the folic acid levels of fortified products [<xref rid="B90-nutrients-17-02752" ref-type="bibr">90</xref>]. This underscores the importance of daily periconceptional supplementation with 400 &#181;g of folic acid, as fortification alone may be insufficient to achieve optimal preventive levels.</p><p>The public health system provides folic acid in two formulations: a 200 &#181;g/mL liquid solution and 5000 &#181;g tablets, both included in the Brazilian National Essential Medicines List [<xref rid="B91-nutrients-17-02752" ref-type="bibr">91</xref>]. To achieve the recommended daily intake of 400 &#181;g during the periconceptional period, women must take 40 drops of the liquid formulation, an inconvenient regimen that raises concerns about adherence. Unpublished data from our research group indicate that the 5000 &#181;g tablet originally intended for high-risk groups has been frequently prescribed, regardless of individual risk profiles (Ethical Approval No. 79644924.0.0000.5327).</p><p>This widespread use of high-dose folic acid supplementation raises concerns about overexposure and potential adverse health effects. A non-controlled intervention study with 30 healthy Brazilian adults showed that daily folic acid supplementation at a 5000 &#181;g dose for 90 days resulted in elevated circulating concentrations of UMFA [<xref rid="B92-nutrients-17-02752" ref-type="bibr">92</xref>]. Similar findings were reported in a case&#8211;control study involving patients with hereditary spherocytosis [<xref rid="B93-nutrients-17-02752" ref-type="bibr">93</xref>].</p><p>While some women may be exposed to high doses of folic acid, a substantial proportion receive no supplementation during the most critical period [<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>]. Most pregnancies in Brazil are unplanned [<xref rid="B94-nutrients-17-02752" ref-type="bibr">94</xref>], and many women fail to initiate supplementation within the periconceptional window [<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>]. This results in two contrasting scenarios: inadequate folic acid intake during key stages of fetal development in some women, and excessive intake without clinical justification in others. A study conducted at a hospital in southern Brazil reported that only 1.6% of women followed national recommendations regarding dosage and timing [<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>]. Another study found that only 8.9% of Brazilian women used folic acid-containing supplements during the first trimester of pregnancy [<xref rid="B95-nutrients-17-02752" ref-type="bibr">95</xref>].</p><p>Another challenge stemming from the inconsistency between national recommendations and the folic acid formulations available in the public health system is the adoption of alternative regimens by clinicians. As observed in the unpublished data from our group, some healthcare providers prescribe the 5000 &#181;g tablet at non-daily intervals. However, given that folic acid is a water-soluble vitamin and is not stored in large amounts [<xref rid="B96-nutrients-17-02752" ref-type="bibr">96</xref>], such strategies may lead to suboptimal bioavailability. This gap has also encouraged recommendations for commercial multivitamins not supplied by the public health system. These products are often expensive for many women, and, in some cases, the costs of purchasing these supplements may divert limited financial resources away from other essential needs, such as nutritious food. Additionally, most commercial supplements now contain 5-MTHF instead of folic acid, despite the lack of evidence supporting 5-MTHF&#8217;s effectiveness in preventing NTDs [<xref rid="B63-nutrients-17-02752" ref-type="bibr">63</xref>].</p><p>These complex and sometimes contradictory realities underscore the urgent need for more precise, accessible, and equitable public health policies. Improved training and education for healthcare providers is also essential to ensure that folic acid recommendations are both effective and appropriately tailored to Brazil&#8217;s unique social, economic, and genetic landscape.</p></sec><sec id="sec5-nutrients-17-02752"><title>5. Future Directions</title><sec id="sec5dot1-nutrients-17-02752"><title>5.1. Directions for Brazil</title><p>Both short- and long-term strategies are needed to ensure folic acid supplementation is effective, safe, and equitable in Brazil. In the short term, efforts should focus on strengthening the training and awareness of healthcare providers, particularly those in primary care and those prescribing medications known to interfere with folate metabolism (e.g., anticonvulsants, methotrexate, sulfasalazine) [<xref rid="B97-nutrients-17-02752" ref-type="bibr">97</xref>]. Developing a specific national guideline focused on folic acid supplementation would be a crucial step toward standardizing clinical practice. In parallel, public health campaigns tailored to Brazil&#8217;s diverse sociocultural and economic contexts are necessary to promote the importance of consistent supplementation, before and through the first trimester of pregnancy. These campaigns should address accessibility barriers, low literacy levels, and regional disparities. In areas with limited access to healthcare, initiatives that bring healthcare providers directly to schools, community centers, and homes should be prioritized. Training health professionals to communicate the benefits of folic acid supplementation in a clear and approachable manner is also essential, using visual aids, videos, and face-to-face interactions to enhance understanding and engagement.</p><p>In the long term, the public health system should incorporate user-friendly formulations, such as 400 &#181;g folic acid tablets, which align with national recommendations and could improve adherence by simplifying the supplementation regimen. To support this strategy, studies assessing the cost-effectiveness and budgetary impact of including the 400 &#181;g formulation in the SUS are needed. Broader access to the appropriate dose formulation could also reduce the growing use of alternative regimens. These studies should comprehensively evaluate the impact of increased folic acid supplementation adherence on the prevention of NTDs and other folate-related conditions, as well as the associated healthcare cost savings. These savings include avoided expenses for surgical interventions, hospital admissions, long-term rehabilitation, and productivity losses from family members. Direct program costs, such as medication procurement, distribution, and storage, must also be considered. Additionally, cost-effectiveness analyses should model different scenarios of adherence rates and regional disparities. Post-implementation, robust monitoring and evaluation systems will be necessary to assess whether the inclusion of the 400 &#181;g formulation in the SUS translates into measurable improvements in maternal and child health outcomes and generates economic benefits for the healthcare system.</p><p>In parallel with improved supplementation strategies, effective monitoring systems are needed to assess folate status at the population level. This is especially critical in countries with folic acid fortification policies, such as Brazil, where actual intake varies due to individual dietary patterns. Because folic acid intake from fortified foods cannot be precisely estimated, biomarker-based surveillance is essential for accurately evaluating folate levels. Additionally, stricter regulatory oversight is necessary to ensure that fortified flours consistently meet the legally mandated folic acid levels, as many products currently fail to meet these requirements [<xref rid="B88-nutrients-17-02752" ref-type="bibr">88</xref>].</p><p>Therefore, investment in national surveillance systems to monitor blood folate concentrations, supplementation coverage, and NTD outcomes is critical to support more effective and targeted public health interventions. Locally driven research initiatives are also critical. These should focus on generating evidence for optimal supplementation strategies in the Brazilian context, including dose&#8211;response assessments, and evaluating common genetic polymorphisms in folate metabolism enzymes, such as the <italic toggle="yes">MTHFR</italic> gene. These efforts would support the development of a national guideline that considers Brazil&#8217;s unique demographic, clinical, and genetic characteristics.</p></sec><sec id="sec5dot2-nutrients-17-02752"><title>5.2. Global Directions</title><p>Many of the challenges faced by Brazil are similar in other low- and middle-income countries, where socioeconomic vulnerabilities, limited access to healthcare, and lower education levels can impair adherence to folic acid supplementation [<xref rid="B77-nutrients-17-02752" ref-type="bibr">77</xref>,<xref rid="B98-nutrients-17-02752" ref-type="bibr">98</xref>]. Globally, additional challenges include public confusion around supplementation regimens, particularly regarding the use of 5-MTHF and the impact of misinformation. Sensationalized media coverage and misinterpretation of scientific findings have fueled unfounded claims, such as the notion that high folate levels cause autism spectrum disorder or that 5-MTHF is universally superior to folic acid, despite the lack of supporting evidence. These narratives erode public trust and reduce adherence to evidence-based recommendations. Addressing these issues requires coordinated efforts in science communication, digital literacy, and developing accessible, transparent public health messaging.</p><p>Another global concern relates to the high prevalence of unplanned pregnancies [<xref rid="B36-nutrients-17-02752" ref-type="bibr">36</xref>] and the increasing use of folate-depleting medications, such as anticonvulsants prescribed not only for epilepsy but also for mood disorders and migraine [<xref rid="B99-nutrients-17-02752" ref-type="bibr">99</xref>]. In light of this, routine folic acid supplementation should be considered for all women of reproductive age who are prescribed such medications. This emphasizes the need for clear, updated clinical guidelines and improved training for healthcare providers on optimal dosage, timing, and target populations. <xref rid="nutrients-17-02752-f002" ref-type="fig">Figure 2</xref> presents a clinical decision tree for folic acid supplementation.</p><p>Ultimately, personalized approaches to folic acid supplementation may be considered. Countries like Canada, for example, have adopted targeted screening of serum or red blood cell folate levels in specific groups, such as women planning pregnancy, those already pregnant, or those taking medications with antifolate effects [<xref rid="B100-nutrients-17-02752" ref-type="bibr">100</xref>]. This personalized approach may inform tailored supplementation strategies, including adjustments of dose throughout pregnancy, thus supporting more precise clinical decision-making.</p><p>A global research agenda is needed to fill critical knowledge gaps, particularly in underrepresented populations. This includes large-scale trials evaluating different folate forms, studies on the impact of extended supplementation during pregnancy, and exploration of population-level genetic variability in folate metabolism. Together, these national and international strategies can help bridge the gap between evidence and policy, ensuring that folic acid supplementation is implemented in a way that is both effective and equitable across diverse global contexts. <xref rid="nutrients-17-02752-f003" ref-type="fig">Figure 3</xref> highlights the main challenges, consequences, and future directions of folic acid supplementation in both the Brazilian and global contexts.</p></sec></sec><sec sec-type="conclusions" id="sec6-nutrients-17-02752"><title>6. Conclusions</title><p>Both insufficient and excessive folic acid exposures raise important concerns for maternal&#8211;child health globally. In parallel, alternative folate formulations, such as 5-MTHF, have been commercialized despite a lack of clinical evidence supporting their efficacy in preventing NTDs, underscoring the urgent need for robust clinical trials to evaluate the effectiveness of different regimens. While this discussion centers on Brazil, many of the challenges and proposed strategies are equally relevant to other low- and middle-income countries facing similar structural, socioeconomic, and genetic diversity barriers. These insights may therefore inform broader international efforts to optimize supplementation policies and practices. Ultimately, there is a pressing need to reassess current strategies through the lens of population-specific data, genetic variability, and optimal dosing and timing. This approach should not only aim to enhance the effectiveness and equity of NTD prevention but also to realize the broader health benefits of adequate folate status throughout the reproductive period and early life.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.K.R. and T.W.K., Writing&#8212;Original Draft Preparation, M.K.R., Writing&#8212;Review and Editing, R.R., L.S.-F., M.T.V.S., and T.W.K., Visualization, M.K.R., Supervision, M.T.V.S. and T.W.K., Project Administration, T.W.K., Funding Acquisition, T.W.K. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data availability statement is not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CDC</td><td align="left" valign="middle" rowspan="1" colspan="1">Center for Disease Control and Prevention</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MTHFR</td><td align="left" valign="middle" rowspan="1" colspan="1">Methylenetetrahydrofolate reductase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5-MTHF</td><td align="left" valign="middle" rowspan="1" colspan="1">5-methyltetrahydrofolate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NTD</td><td align="left" valign="middle" rowspan="1" colspan="1">Neural tube defect</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RCT</td><td align="left" valign="middle" rowspan="1" colspan="1">Randomized clinical trial</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SUS</td><td align="left" valign="middle" rowspan="1" colspan="1">Sistema &#218;nico de Sa&#250;de (Unified Health System)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">UMFA</td><td align="left" valign="middle" rowspan="1" colspan="1">Unmetabolized folic acid</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-nutrients-17-02752"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brink</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Bender</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>R.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Miketinas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>N.</given-names></name><name name-style="western"><surname>Loveridge</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gross</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fawkes</surname><given-names>N.</given-names></name></person-group><article-title>Optimizing Maternal Nutrition: The Importance of a Tailored Approach</article-title><source>Curr. Dev. Nutr.</source><year>2022</year><volume>6</volume><fpage>118</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1093/cdn/nzac118</pub-id><pub-id pub-id-type="pmcid">PMC9492153</pub-id><pub-id pub-id-type="pmid">36157850</pub-id></element-citation></ref><ref id="B2-nutrients-17-02752"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shulpekova</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nechaev</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kardasheva</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sedova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kurbatova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bueverova</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kopylov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Malsagova</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dlamini</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Ivashkin</surname><given-names>V.</given-names></name></person-group><article-title>The Concept of Folic Acid in Health and Disease</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>3731</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26123731</pub-id><pub-id pub-id-type="pmid">34207319</pub-id><pub-id pub-id-type="pmcid">PMC8235569</pub-id></element-citation></ref><ref id="B3-nutrients-17-02752"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czeizel</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Dud&#225;s</surname><given-names>I.</given-names></name><name name-style="western"><surname>Vereczkey</surname><given-names>A.</given-names></name><name name-style="western"><surname>B&#225;nhidy</surname><given-names>F.</given-names></name></person-group><article-title>Folate Deficiency and Folic Acid Supplementation: The Prevention of Neural-Tube Defects and Congenital Heart Defects</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><fpage>4760</fpage><lpage>4775</lpage><pub-id pub-id-type="doi">10.3390/nu5114760</pub-id><pub-id pub-id-type="pmid">24284617</pub-id><pub-id pub-id-type="pmcid">PMC3847759</pub-id></element-citation></ref><ref id="B4-nutrients-17-02752"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steegers-Theunissen</surname><given-names>R.P.M.</given-names></name><name name-style="western"><surname>Twigt</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pestinger</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sinclair</surname><given-names>K.D.</given-names></name></person-group><article-title>The Periconceptional Period, Reproduction and Long-Term Health of Offspring: The Importance of One-Carbon Metabolism</article-title><source>Hum. Reprod. Update</source><year>2013</year><volume>19</volume><fpage>640</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1093/humupd/dmt041</pub-id><pub-id pub-id-type="pmid">23959022</pub-id></element-citation></ref><ref id="B5-nutrients-17-02752"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avagliano</surname><given-names>L.</given-names></name><name name-style="western"><surname>Massa</surname><given-names>V.</given-names></name><name name-style="western"><surname>George</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Qureshy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bulfamante</surname><given-names>G.</given-names></name><name name-style="western"><surname>Finnell</surname><given-names>R.H.</given-names></name></person-group><article-title>Overview on Neural Tube Defects: From Development to Physical Characteristics</article-title><source>Birth Defects Res.</source><year>2019</year><volume>111</volume><fpage>1455</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1002/bdr2.1380</pub-id><pub-id pub-id-type="pmid">30421543</pub-id><pub-id pub-id-type="pmcid">PMC6511489</pub-id></element-citation></ref><ref id="B6-nutrients-17-02752"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gleeson</surname><given-names>J.G.</given-names></name></person-group><article-title>Closing in on Mechanisms of Open Neural Tube Defects</article-title><source>Trends Neurosci.</source><year>2020</year><volume>43</volume><fpage>519</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2020.04.009</pub-id><pub-id pub-id-type="pmid">32423763</pub-id><pub-id pub-id-type="pmcid">PMC7321880</pub-id></element-citation></ref><ref id="B7-nutrients-17-02752"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kancherla</surname><given-names>V.</given-names></name></person-group><article-title>Neural Tube Defects: A Review of Global Prevalence, Causes, and Primary Prevention</article-title><source>Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.</source><year>2023</year><volume>39</volume><fpage>1703</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1007/s00381-023-05910-7</pub-id><pub-id pub-id-type="pmid">36882610</pub-id></element-citation></ref><ref id="B8-nutrients-17-02752"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebara</surname><given-names>S.</given-names></name></person-group><article-title>Nutritional Role of Folate</article-title><source>Congenit. Anom.</source><year>2017</year><volume>57</volume><fpage>138</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1111/cga.12233</pub-id><pub-id pub-id-type="pmid">28603928</pub-id></element-citation></ref><ref id="B9-nutrients-17-02752"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenquist</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Finnell</surname><given-names>R.H.</given-names></name></person-group><article-title>Genes, Folate and Homocysteine in Embryonic Development</article-title><source>Proc. Nutr. Soc.</source><year>2001</year><volume>60</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1017/S0029665101000088</pub-id><pub-id pub-id-type="pmid">11310424</pub-id></element-citation></ref><ref id="B10-nutrients-17-02752"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>M.</given-names></name><name name-style="western"><surname>Halsey</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sherliker</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>R.</given-names></name></person-group><article-title>Global Heterogeneity in Folic Acid Fortification Policies and Implications for Prevention of Neural Tube Defects and Stroke: A Systematic Review</article-title><source>EClinicalMedicine</source><year>2024</year><volume>67</volume><fpage>102366</fpage><lpage>102378</lpage><pub-id pub-id-type="doi">10.1016/j.eclinm.2023.102366</pub-id><pub-id pub-id-type="pmid">38169713</pub-id><pub-id pub-id-type="pmcid">PMC10758734</pub-id></element-citation></ref><ref id="B11-nutrients-17-02752"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>U.S. Preventive Services Task Force</collab></person-group><article-title>Folic Acid for the Prevention of Neural Tube Defects: U.S. Preventive Services Task Force Recommendation Statement</article-title><source>Ann. Intern. Med.</source><year>2009</year><volume>150</volume><fpage>626</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-150-9-200905050-00009</pub-id><pub-id pub-id-type="pmid">19414842</pub-id></element-citation></ref><ref id="B12-nutrients-17-02752"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atta</surname><given-names>C.A.M.</given-names></name><name name-style="western"><surname>Fiest</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Frolkis</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Jette</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pringsheim</surname><given-names>T.</given-names></name><name name-style="western"><surname>St Germaine-Smith</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rajapakse</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Metcalfe</surname><given-names>A.</given-names></name></person-group><article-title>Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis</article-title><source>Am. J. Public Health</source><year>2016</year><volume>106</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2015.302902</pub-id><pub-id pub-id-type="pmcid">PMC4695937</pub-id><pub-id pub-id-type="pmid">26562127</pub-id></element-citation></ref><ref id="B13-nutrients-17-02752"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fardous</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Heydari</surname><given-names>A.R.</given-names></name></person-group><article-title>Uncovering the Hidden Dangers and Molecular Mechanisms of Excess Folate: A Narrative Review</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>4699</elocation-id><pub-id pub-id-type="doi">10.3390/nu15214699</pub-id><pub-id pub-id-type="pmid">37960352</pub-id><pub-id pub-id-type="pmcid">PMC10648405</pub-id></element-citation></ref><ref id="B14-nutrients-17-02752"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hauser</surname><given-names>W.A.</given-names></name></person-group><article-title>Folic Acid Supplementation: Too Much of a Good Thing?</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2009</year><volume>80</volume><fpage>468</fpage><pub-id pub-id-type="doi">10.1136/jnnp.2008.169516</pub-id><pub-id pub-id-type="pmid">19372285</pub-id></element-citation></ref><ref id="B15-nutrients-17-02752"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>C.</given-names></name><name name-style="western"><surname>Keating</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>E.</given-names></name></person-group><article-title>The Impact of Folic Acid Supplementation on Gestational and Long Term Health: Critical Temporal Windows, Benefits and Risks</article-title><source>Porto Biomed. J.</source><year>2017</year><volume>2</volume><fpage>315</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.pbj.2017.05.006</pub-id><pub-id pub-id-type="pmid">32258789</pub-id><pub-id pub-id-type="pmcid">PMC6806748</pub-id></element-citation></ref><ref id="B16-nutrients-17-02752"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrazzi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tiso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Di Martino</surname><given-names>D.</given-names></name></person-group><article-title>Folic Acid versus 5- Methyl Tetrahydrofolate Supplementation in Pregnancy</article-title><source>Eur. J. Obstet. Gynecol. Reprod. Biol.</source><year>2020</year><volume>253</volume><fpage>312</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.ejogrb.2020.06.012</pub-id><pub-id pub-id-type="pmid">32868164</pub-id></element-citation></ref><ref id="B17-nutrients-17-02752"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidmar Golja</surname><given-names>M.</given-names></name><name name-style="western"><surname>&#352;mid</surname><given-names>A.</given-names></name><name name-style="western"><surname>Karas Ku&#382;eli&#269;ki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Trontelj</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ger&#353;ak</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mlinari&#269;-Ra&#353;&#269;an</surname><given-names>I.</given-names></name></person-group><article-title>Folate Insufficiency Due to MTHFR Deficiency Is Bypassed by 5-Methyltetrahydrofolate</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>2836</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9092836</pub-id><pub-id pub-id-type="pmid">32887268</pub-id><pub-id pub-id-type="pmcid">PMC7564482</pub-id></element-citation></ref><ref id="B18-nutrients-17-02752"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Thier</surname><given-names>K.</given-names></name></person-group><article-title>Why Do People Believe Health Misinformation and Who Is at Risk? A Systematic Review of Individual Differences in Susceptibility to Health Misinformation</article-title><source>Soc. Sci. Med.</source><year>2022</year><volume>314</volume><fpage>115398</fpage><pub-id pub-id-type="doi">10.1016/j.socscimed.2022.115398</pub-id><pub-id pub-id-type="pmid">36327631</pub-id></element-citation></ref><ref id="B19-nutrients-17-02752"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Gubert</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>L.M.P.</given-names></name></person-group><article-title>Folic Acid Intake by Pregnant Women from Vale Do Jequitinhonha, Brazil, and the Contribution of Fortified Foods</article-title><source>Arch. Latinoam. Nutr.</source><year>2015</year><volume>65</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">26320303</pub-id></element-citation></ref><ref id="B20-nutrients-17-02752"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Rosa</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Silveira</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Correia</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Grapiglia</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>de Moraes</surname><given-names>S.A.G.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Zen</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Correia</surname><given-names>E.P.E.</given-names></name><name name-style="western"><surname>Alcay</surname><given-names>C.T.</given-names></name><etal/></person-group><article-title>Periconceptional Folic Acid Supplementation in Southern Brazil: Why Are Not We Doing It Right?</article-title><source>Am. J. Med. Genet. A</source><year>2019</year><volume>179</volume><fpage>20</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.60699</pub-id><pub-id pub-id-type="pmid">30569628</pub-id></element-citation></ref><ref id="B21-nutrients-17-02752"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Czeizel</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Dud&#225;s</surname><given-names>I.</given-names></name></person-group><article-title>Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation</article-title><source>N. Engl. J. Med.</source><year>1992</year><volume>327</volume><fpage>1832</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1056/NEJM199212243272602</pub-id><pub-id pub-id-type="pmid">1307234</pub-id></element-citation></ref><ref id="B22-nutrients-17-02752"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>MRC Vitamin Study Research Group</collab></person-group><article-title>Prevention of Neural Tube Defects: Results of the Medical Research Council Vitamin Study</article-title><source>Lancet</source><year>1991</year><volume>338</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(91)90133-A</pub-id><pub-id pub-id-type="pmid">1677062</pub-id></element-citation></ref><ref id="B23-nutrients-17-02752"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laurence</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>James</surname><given-names>N.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Tennant</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>H.</given-names></name></person-group><article-title>Double-Blind Randomised Controlled Trial of Folate Treatment before Conception to Prevent Recurrence of Neural-Tube Defects</article-title><source>Br. Med. J. Clin. Res. Ed.</source><year>1981</year><volume>282</volume><fpage>1509</fpage><lpage>1511</lpage><pub-id pub-id-type="doi">10.1136/bmj.282.6275.1509</pub-id><pub-id pub-id-type="pmcid">PMC1505459</pub-id><pub-id pub-id-type="pmid">6786536</pub-id></element-citation></ref><ref id="B24-nutrients-17-02752"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hibbard</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Hibbard</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Jeffcoate</surname><given-names>T.N.</given-names></name></person-group><article-title>Folic Acid and Reproduction</article-title><source>Acta Obstet. Gynecol. Scand.</source><year>1965</year><volume>44</volume><fpage>375</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.3109/00016346509155874</pub-id><pub-id pub-id-type="pmid">5863074</pub-id></element-citation></ref><ref id="B25-nutrients-17-02752"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smithells</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schorah</surname><given-names>C.J.</given-names></name></person-group><article-title>Vitamin Dificiencies and Neural Tube Defects</article-title><source>Arch. Dis. Child.</source><year>1976</year><volume>51</volume><fpage>944</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1136/adc.51.12.944</pub-id><pub-id pub-id-type="pmid">1015847</pub-id><pub-id pub-id-type="pmcid">PMC1546171</pub-id></element-citation></ref><ref id="B26-nutrients-17-02752"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smithells</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schorah</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Seller</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Nevin</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>R.</given-names></name><name name-style="western"><surname>Read</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>D.W.</given-names></name></person-group><article-title>Apparent Prevention of Neural Tube Defects by Periconceptional Vitamin Supplementation</article-title><source>Arch. Dis. Child.</source><year>1981</year><volume>56</volume><fpage>911</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1136/adc.56.12.911</pub-id><pub-id pub-id-type="pmid">7332338</pub-id><pub-id pub-id-type="pmcid">PMC1627490</pub-id></element-citation></ref><ref id="B27-nutrients-17-02752"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smithells</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schorah</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Seller</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Nevin</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>R.</given-names></name><name name-style="western"><surname>Read</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>D.W.</given-names></name></person-group><article-title>Possible Prevention of Neural-Tube Defects by Periconceptional Vitamin Supplementation</article-title><source>Lancet</source><year>1980</year><volume>1</volume><fpage>339</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(80)90886-7</pub-id><pub-id pub-id-type="pmid">6101792</pub-id></element-citation></ref><ref id="B28-nutrients-17-02752"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smithells</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Nevin</surname><given-names>N.C.</given-names></name><name name-style="western"><surname>Seller</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>R.</given-names></name><name name-style="western"><surname>Read</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schorah</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Wild</surname><given-names>J.</given-names></name></person-group><article-title>Further Experience of Vitamin Supplementation for Prevention of Neural Tube Defect Recurrences</article-title><source>Lancet</source><year>1983</year><volume>1</volume><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(83)92654-5</pub-id><pub-id pub-id-type="pmid">6133069</pub-id></element-citation></ref><ref id="B29-nutrients-17-02752"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name></person-group><article-title>Neural Tube Defects and Folate Deficiency: Is DNA Repair Defective?</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>2220</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24032220</pub-id><pub-id pub-id-type="pmid">36768542</pub-id><pub-id pub-id-type="pmcid">PMC9916799</pub-id></element-citation></ref><ref id="B30-nutrients-17-02752"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control (CDC)</collab></person-group><article-title>Use of Folic Acid for Prevention of Spina Bifida and Other Neural Tube Defects&#8212;1983&#8211;1991</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>1991</year><volume>40</volume><fpage>513</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1001/jama.1991.03470090024009</pub-id><pub-id pub-id-type="pmid">2072886</pub-id></element-citation></ref><ref id="B31-nutrients-17-02752"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control</collab></person-group><article-title>Recommendations for the Use of Folic Acid to Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects</article-title><source>MMWR Recomm. Rep. Morb. Mortal. Wkly. Rep. Recomm. Rep.</source><year>1992</year><volume>41</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1522835</pub-id></element-citation></ref><ref id="B32-nutrients-17-02752"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine (US)</collab></person-group><article-title>Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline</article-title><source>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline</source><publisher-name>National Academies Press</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>1998</year><isbn>978-0-309-06411-8</isbn><pub-id pub-id-type="pmid">23193625</pub-id></element-citation></ref><ref id="B33-nutrients-17-02752"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuncalp</surname><given-names>&#214;.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Lawrie</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Barreix</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pe&#241;a-Rosas</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Bucagu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Neilson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Oladapo</surname><given-names>O.T.</given-names></name></person-group><article-title>WHO Recommendations on Antenatal Nutrition: An Update on Multiple Micronutrient Supplements</article-title><source>BMJ Glob. Health</source><year>2020</year><volume>5</volume><fpage>3375</fpage><lpage>3379</lpage><pub-id pub-id-type="doi">10.1136/bmjgh-2020-003375</pub-id><pub-id pub-id-type="pmcid">PMC7394017</pub-id><pub-id pub-id-type="pmid">32732247</pub-id></element-citation></ref><ref id="B34-nutrients-17-02752"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cawley</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mullaney</surname><given-names>L.</given-names></name><name name-style="western"><surname>McKeating</surname><given-names>A.</given-names></name><name name-style="western"><surname>Farren</surname><given-names>M.</given-names></name><name name-style="western"><surname>McCartney</surname><given-names>D.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>M.J.</given-names></name></person-group><article-title>A Review of European Guidelines on Periconceptional Folic Acid Supplementation</article-title><source>Eur. J. Clin. Nutr.</source><year>2016</year><volume>70</volume><fpage>143</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2015.131</pub-id><pub-id pub-id-type="pmid">26350391</pub-id></element-citation></ref><ref id="B35-nutrients-17-02752"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botto</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Lisi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Robert-Gnansia</surname><given-names>E.</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Vollset</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Mastroiacovo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Botting</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cocchi</surname><given-names>G.</given-names></name><name name-style="western"><surname>de Vigan</surname><given-names>C.</given-names></name><name name-style="western"><surname>de Walle</surname><given-names>H.</given-names></name><etal/></person-group><article-title>International Retrospective Cohort Study of Neural Tube Defects in Relation to Folic Acid Recommendations: Are the Recommendations Working?</article-title><source>BMJ</source><year>2005</year><volume>330</volume><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1136/bmj.38336.664352.82</pub-id><pub-id pub-id-type="pmid">15722368</pub-id><pub-id pub-id-type="pmcid">PMC554029</pub-id></element-citation></ref><ref id="B36-nutrients-17-02752"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finer</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Henshaw</surname><given-names>S.K.</given-names></name></person-group><article-title>Disparities in Rates of Unintended Pregnancy in the United States, 1994 and 2001</article-title><source>Perspect. Sex. Reprod. Health</source><year>2006</year><volume>38</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1363/3809006</pub-id><pub-id pub-id-type="pmid">16772190</pub-id></element-citation></ref><ref id="B37-nutrients-17-02752"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>G.</given-names></name><name name-style="western"><surname>Burrows</surname><given-names>R.F.</given-names></name></person-group><article-title>Evidence for Suboptimal Use of Periconceptional Folic Acid Supplements Globally</article-title><source>Int. J. Obstet. Gynaecol.</source><year>2004</year><volume>111</volume><fpage>399</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1111/j.1471-0528.2004.00115.x</pub-id><pub-id pub-id-type="pmid">15104602</pub-id></element-citation></ref><ref id="B38-nutrients-17-02752"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blencowe</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cousens</surname><given-names>S.</given-names></name><name name-style="western"><surname>Modell</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lawn</surname><given-names>J.</given-names></name></person-group><article-title>Folic Acid to Reduce Neonatal Mortality from Neural Tube Disorders</article-title><source>Int. J. Epidemiol.</source><year>2010</year><volume>39</volume><issue>(Suppl. 1)</issue><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1093/ije/dyq028</pub-id><pub-id pub-id-type="pmcid">PMC2845867</pub-id><pub-id pub-id-type="pmid">20348114</pub-id></element-citation></ref><ref id="B39-nutrients-17-02752"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crider</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y.P.</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Mai</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Zauche</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>K.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>J.L.</given-names></name></person-group><article-title>Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies</article-title><source>Annu. Rev. Nutr.</source><year>2022</year><volume>42</volume><fpage>423</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1146/annurev-nutr-043020-091647</pub-id><pub-id pub-id-type="pmid">35995050</pub-id><pub-id pub-id-type="pmcid">PMC9875360</pub-id></element-citation></ref><ref id="B40-nutrients-17-02752"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Silva</surname><given-names>C.A.P.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>C.A.P.</given-names></name><name name-style="western"><surname>Atallah</surname><given-names>&#193;.N.</given-names></name><name name-style="western"><surname>Sass</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>E.T.R.</given-names></name><name name-style="western"><surname>Peixoto</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of Calcium and Folic Acid Supplementation in Prenatal Care in S&#227;o Paulo</article-title><source>Sao Paulo Med. J.</source><year>2010</year><volume>128</volume><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1590/S1516-31802010000600003</pub-id><pub-id pub-id-type="pmid">21308154</pub-id><pub-id pub-id-type="pmcid">PMC10948075</pub-id></element-citation></ref><ref id="B41-nutrients-17-02752"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mezzomo</surname><given-names>C.L.S.</given-names></name><name name-style="western"><surname>Garcias</surname><given-names>G.d.L.</given-names></name><name name-style="western"><surname>Sclowitz</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Sclowitz</surname><given-names>I.T.</given-names></name><name name-style="western"><surname>Brum</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Fontana</surname><given-names>T.</given-names></name><name name-style="western"><surname>Unfried</surname><given-names>R.I.</given-names></name></person-group><article-title>Preven&#231;&#227;o de defeitos do tubo neural: Preval&#234;ncia do uso da suplementa&#231;&#227;o de &#225;cido f&#243;lico e fatores associados em gestantes na cidade de Pelotas, Rio Grande do Sul, Brasil</article-title><source>Cad. Sa&#250;de P&#250;blica</source><year>2007</year><volume>23</volume><fpage>2716</fpage><lpage>2726</lpage><pub-id pub-id-type="doi">10.1590/S0102-311X2007001100019</pub-id><pub-id pub-id-type="pmid">17952264</pub-id></element-citation></ref><ref id="B42-nutrients-17-02752"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nosrat</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Sedehi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Golalipour</surname><given-names>M.J.</given-names></name></person-group><article-title>Knowledge and Practice of Urban Iranian Pregnant Women towards Folic Acid Intake for Neural Tube Defect Prevention</article-title><source>J. Pak. Med. Assoc.</source><year>2012</year><volume>62</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">23862250</pub-id></element-citation></ref><ref id="B43-nutrients-17-02752"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anzaku</surname><given-names>A.S.</given-names></name></person-group><article-title>Assessing Folic Acid Awareness and Its Usage for the Prevention of Neural Tube Defects Among Pregnant Women in Jos, Nigeria</article-title><source>J. Basic Clin. Reprod. Sci.</source><year>2013</year><volume>2</volume><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.4103/2278-960X.112574</pub-id></element-citation></ref><ref id="B44-nutrients-17-02752"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammed</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Bushra</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Aljadhey</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>J.H.</given-names></name></person-group><article-title>Supplement Use Among Pregnant Women in Ethiopia: Prevalence and Predictors</article-title><source>Ther. Innov. Regul. Sci.</source><year>2013</year><volume>47</volume><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1177/2168479013485078</pub-id><pub-id pub-id-type="pmid">30235523</pub-id></element-citation></ref><ref id="B45-nutrients-17-02752"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xing</surname><given-names>X.-Y.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>F.-B.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.-H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X.-M.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L.-M.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>D.-J.</given-names></name><name name-style="western"><surname>Su</surname><given-names>P.-Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Periconceptional Folic Acid Supplementation among Women Attending Antenatal Clinic in Anhui, China: Data from a Population-Based Cohort Study</article-title><source>Midwifery</source><year>2012</year><volume>28</volume><fpage>291</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.midw.2011.04.002</pub-id><pub-id pub-id-type="pmid">22015219</pub-id></element-citation></ref><ref id="B46-nutrients-17-02752"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.-L.</given-names></name><name name-style="western"><surname>Lyu</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.-L.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X.-Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name></person-group><article-title>Knowledge and Intake of Folic Acid to Prevent Neural Tube Defects among Pregnant Women in Urban China: A Cross-Sectional Study</article-title><source>BMC Pregnancy Childbirth</source><year>2021</year><volume>21</volume><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1186/s12884-021-03893-4</pub-id><pub-id pub-id-type="pmid">34154557</pub-id><pub-id pub-id-type="pmcid">PMC8218380</pub-id></element-citation></ref><ref id="B47-nutrients-17-02752"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siatka</surname><given-names>T.</given-names></name><name name-style="western"><surname>M&#225;t&#8217;u&#353;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moravcov&#225;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Har&#269;&#225;rov&#225;</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lomozov&#225;</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Matou&#353;ov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>Suwanvecho</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kr&#269;mov&#225;</surname><given-names>L.K.</given-names></name><name name-style="western"><surname>Mlad&#283;nka</surname><given-names>P.</given-names></name></person-group><article-title>Biological, Dietetic and Pharmacological Properties of Vitamin B9</article-title><source>NPJ Sci. Food</source><year>2025</year><volume>9</volume><fpage>30</fpage><pub-id pub-id-type="doi">10.1038/s41538-025-00396-w</pub-id><pub-id pub-id-type="pmid">40075081</pub-id><pub-id pub-id-type="pmcid">PMC11904035</pub-id></element-citation></ref><ref id="B48-nutrients-17-02752"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A.</given-names></name><name name-style="western"><surname>Troen</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Mason</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Selhub</surname><given-names>J.</given-names></name></person-group><article-title>Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?</article-title><source>Food Nutr. Bull.</source><year>2024</year><volume>45</volume><fpage>S67</fpage><lpage>S72</lpage><pub-id pub-id-type="doi">10.1177/03795721241229503</pub-id><pub-id pub-id-type="pmid">38987872</pub-id><pub-id pub-id-type="pmcid">PMC11288374</pub-id></element-citation></ref><ref id="B49-nutrients-17-02752"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L.</given-names></name></person-group><article-title>The Influence of Maternal Folate Status on Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>2766</elocation-id><pub-id pub-id-type="doi">10.3390/nu15122766</pub-id><pub-id pub-id-type="pmid">37375669</pub-id><pub-id pub-id-type="pmcid">PMC10300922</pub-id></element-citation></ref><ref id="B50-nutrients-17-02752"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishnaveni</surname><given-names>G.V.</given-names></name><name name-style="western"><surname>Veena</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Karat</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Yajnik</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Fall</surname><given-names>C.H.D.</given-names></name></person-group><article-title>Association between Maternal Folate Concentrations during Pregnancy and Insulin Resistance in Indian Children</article-title><source>Diabetologia</source><year>2014</year><volume>57</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1007/s00125-013-3086-7</pub-id><pub-id pub-id-type="pmid">24162586</pub-id><pub-id pub-id-type="pmcid">PMC3855580</pub-id></element-citation></ref><ref id="B51-nutrients-17-02752"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Leyland</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Havdahl</surname><given-names>A.</given-names></name><name name-style="western"><surname>Borge</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shimonovich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dundas</surname><given-names>R.</given-names></name></person-group><article-title>Prenatal Vitamins and the Risk of Offspring Autism Spectrum Disorder: Systematic Review and Meta-Analysis</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>2558</elocation-id><pub-id pub-id-type="doi">10.3390/nu13082558</pub-id><pub-id pub-id-type="pmid">34444717</pub-id><pub-id pub-id-type="pmcid">PMC8398897</pub-id></element-citation></ref><ref id="B52-nutrients-17-02752"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.-X.</given-names></name></person-group><article-title>Prenatal Folic Acid Supplements and Offspring&#8217;s Autism Spectrum Disorder: A Meta-Analysis and Meta-Regression</article-title><source>J. Autism Dev. Disord.</source><year>2022</year><volume>52</volume><fpage>522</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1007/s10803-021-04951-8</pub-id><pub-id pub-id-type="pmid">33743119</pub-id><pub-id pub-id-type="pmcid">PMC8813730</pub-id></element-citation></ref><ref id="B53-nutrients-17-02752"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roffman</surname><given-names>J.L.</given-names></name></person-group><article-title>Neuroprotective Effects of Prenatal Folic Acid Supplementation: Why Timing Matters</article-title><source>JAMA Psychiatry</source><year>2018</year><volume>75</volume><fpage>747</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.0378</pub-id><pub-id pub-id-type="pmid">29801055</pub-id><pub-id pub-id-type="pmcid">PMC6777839</pub-id></element-citation></ref><ref id="B54-nutrients-17-02752"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cs&#225;ky-Szunyogh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vereczkey</surname><given-names>A.</given-names></name><name name-style="western"><surname>K&#243;sa</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gerencs&#233;r</surname><given-names>B.</given-names></name><name name-style="western"><surname>Czeizel</surname><given-names>A.E.</given-names></name></person-group><article-title>Risk Factors in the Origin of Congenital Left-Ventricular Outflow-Tract Obstruction Defects of the Heart: A Population-Based Case-Control Study</article-title><source>Pediatr. Cardiol.</source><year>2014</year><volume>35</volume><fpage>108</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s00246-013-0749-6</pub-id><pub-id pub-id-type="pmid">23843102</pub-id></element-citation></ref><ref id="B55-nutrients-17-02752"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chatzi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Papadopoulou</surname><given-names>E.</given-names></name><name name-style="western"><surname>Koutra</surname><given-names>K.</given-names></name><name name-style="western"><surname>Roumeliotaki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Georgiou</surname><given-names>V.</given-names></name><name name-style="western"><surname>Stratakis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lebentakou</surname><given-names>V.</given-names></name><name name-style="western"><surname>Karachaliou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vassilaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kogevinas</surname><given-names>M.</given-names></name></person-group><article-title>Effect of High Doses of Folic Acid Supplementation in Early Pregnancy on Child Neurodevelopment at 18 Months of Age: The Mother&#8211;Child Cohort &#8216;Rhea&#8217; Study in Crete, Greece</article-title><source>Public Health Nutr.</source><year>2012</year><volume>15</volume><fpage>1728</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.1017/S1368980012000067</pub-id><pub-id pub-id-type="pmid">22314109</pub-id></element-citation></ref><ref id="B56-nutrients-17-02752"><label>56.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Eric</surname><given-names>C.</given-names></name><name name-style="western"><surname>Joel</surname><given-names>M.</given-names></name></person-group><article-title>Folate and Carcinogenesis</article-title><source>Folate in Health and Disease</source><edition>2nd ed.</edition><publisher-name>Routledge Taylor &amp; Francis Group</publisher-name><publisher-loc>Abingdon, UK</publisher-loc><year>2009</year><fpage>235</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1201/9781420071252-c10</pub-id></element-citation></ref><ref id="B57-nutrients-17-02752"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crider</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>R.J.</given-names></name></person-group><article-title>Folic Acid Food Fortification&#8212;Its History, Effect, Concerns, and Future Directions</article-title><source>Nutrients</source><year>2011</year><volume>3</volume><fpage>370</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.3390/nu3030370</pub-id><pub-id pub-id-type="pmid">22254102</pub-id><pub-id pub-id-type="pmcid">PMC3257747</pub-id></element-citation></ref><ref id="B58-nutrients-17-02752"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pastor-Valero</surname><given-names>M.</given-names></name><name name-style="western"><surname>Navarrete-Mu&#241;oz</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Rebagliato</surname><given-names>M.</given-names></name><name name-style="western"><surname>I&#241;iguez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Murcia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ballester</surname><given-names>F.</given-names></name><name name-style="western"><surname>Vioque</surname><given-names>J.</given-names></name></person-group><article-title>Periconceptional Folic Acid Supplementation and Anthropometric Measures at Birth in a Cohort of Pregnant Women in Valencia, Spain</article-title><source>Br. J. Nutr.</source><year>2011</year><volume>105</volume><fpage>1352</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1017/S0007114510005143</pub-id><pub-id pub-id-type="pmid">21272409</pub-id></element-citation></ref><ref id="B59-nutrients-17-02752"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Compa&#241; Gabucio</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Garc&#237;a de la Hera</surname><given-names>M.</given-names></name><name name-style="western"><surname>Torres Collado</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Somoano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tard&#243;n</surname><given-names>A.</given-names></name><name name-style="western"><surname>Guxens</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vrijheid</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rebagliato</surname><given-names>M.</given-names></name><name name-style="western"><surname>Murcia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ibarluzea</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The Use of Lower or Higher Than Recommended Doses of Folic Acid Supplements during Pregnancy Is Associated with Child Attentional Dysfunction at 4&#8211;5 Years of Age in the INMA Project</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>327</elocation-id><pub-id pub-id-type="doi">10.3390/nu13020327</pub-id><pub-id pub-id-type="pmid">33498619</pub-id><pub-id pub-id-type="pmcid">PMC7912326</pub-id></element-citation></ref><ref id="B60-nutrients-17-02752"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>High Dose of Maternal Folic Acid Supplementation Is Associated to Infant Asthma</article-title><source>Food Chem. Toxicol.</source><year>2015</year><volume>75</volume><fpage>88</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2014.11.006</pub-id><pub-id pub-id-type="pmid">25449200</pub-id></element-citation></ref><ref id="B61-nutrients-17-02752"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazili</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name></person-group><article-title>Comparison of Serum Folate Species Analyzed by LC-MS/MS with Total Folate Measured by Microbiologic Assay and Bio-Rad Radioassay</article-title><source>Clin. Chem.</source><year>2007</year><volume>53</volume><fpage>781</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2006.078451</pub-id><pub-id pub-id-type="pmid">17272488</pub-id></element-citation></ref><ref id="B62-nutrients-17-02752"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menezo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Elder</surname><given-names>K.</given-names></name><name name-style="western"><surname>Clement</surname><given-names>A.</given-names></name><name name-style="western"><surname>Clement</surname><given-names>P.</given-names></name></person-group><article-title>Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles</article-title><source>Biomolecules</source><year>2022</year><volume>12</volume><elocation-id>197</elocation-id><pub-id pub-id-type="doi">10.3390/biom12020197</pub-id><pub-id pub-id-type="pmid">35204698</pub-id><pub-id pub-id-type="pmcid">PMC8961567</pub-id></element-citation></ref><ref id="B63-nutrients-17-02752"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samaniego-Vaesken</surname><given-names>M.d.L.</given-names></name><name name-style="western"><surname>Morais-Moreno</surname><given-names>C.</given-names></name><name name-style="western"><surname>Carretero-Krug</surname><given-names>A.</given-names></name><name name-style="western"><surname>Puga</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Montero-Bravo</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Partearroyo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gregorio</surname><given-names>V.-M.</given-names></name></person-group><article-title>Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>3154</elocation-id><pub-id pub-id-type="doi">10.3390/nu16183154</pub-id><pub-id pub-id-type="pmid">39339754</pub-id><pub-id pub-id-type="pmcid">PMC11435031</pub-id></element-citation></ref><ref id="B64-nutrients-17-02752"><label>64.</label><element-citation publication-type="gov"><article-title>CDC (Centers for Disease Control and Prevention) MTHFR Gene Variant and Folic Acid Facts</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/folic-acid/data-research/mthfr/index.html" ext-link-type="uri">https://www.cdc.gov/folic-acid/data-research/mthfr/index.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-06">(accessed on 6 July 2025)</date-in-citation></element-citation></ref><ref id="B65-nutrients-17-02752"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chitayat</surname><given-names>D.</given-names></name><name name-style="western"><surname>Matsui</surname><given-names>D.</given-names></name><name name-style="western"><surname>Amitai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vohra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rieder</surname><given-names>M.</given-names></name><name name-style="western"><surname>Koren</surname><given-names>G.</given-names></name></person-group><article-title>Folic Acid Supplementation for Pregnant Women and Those Planning Pregnancy: 2015 Update</article-title><source>J. Clin. Pharmacol.</source><year>2016</year><volume>56</volume><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1002/jcph.616</pub-id><pub-id pub-id-type="pmid">26272218</pub-id><pub-id pub-id-type="pmcid">PMC4738404</pub-id></element-citation></ref><ref id="B66-nutrients-17-02752"><label>66.</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><article-title>Periconceptional Folic Acid Supplementation to Prevent Neural Tube Defects</article-title><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/tools/elena/interventions/folate-periconceptional" ext-link-type="uri">https://www.who.int/tools/elena/interventions/folate-periconceptional</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-07-06">(accessed on 6 July 2025)</date-in-citation></element-citation></ref><ref id="B67-nutrients-17-02752"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Indrawati</surname></name><name name-style="western"><surname>Hendrickx</surname><given-names>M.</given-names></name></person-group><article-title>Model Studies on the Stability of Folic Acid and 5-Methyltetrahydrofolic Acid Degradation during Thermal Treatment in Combination with High Hydrostatic Pressure</article-title><source>J. Agric. Food Chem.</source><year>2003</year><volume>51</volume><fpage>3352</fpage><lpage>3357</lpage><pub-id pub-id-type="doi">10.1021/jf026234e</pub-id><pub-id pub-id-type="pmid">12744666</pub-id></element-citation></ref><ref id="B68-nutrients-17-02752"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cochrane</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Karakochuk</surname><given-names>C.D.</given-names></name></person-group><article-title>Current Evidence and Controversies Related to Folate Supplementation During Pregnancy</article-title><source>J. Obstet. Gynaecol. Can.</source><year>2024</year><volume>46</volume><fpage>102566</fpage><pub-id pub-id-type="doi">10.1016/j.jogc.2024.102566</pub-id><pub-id pub-id-type="pmid">38821225</pub-id></element-citation></ref><ref id="B69-nutrients-17-02752"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ondi&#269;ov&#225;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Irwin</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Thursby</surname><given-names>S.-J.</given-names></name><name name-style="western"><surname>Hilman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Caffrey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>T.</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lees-Murdock</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Ward</surname><given-names>M.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Folic Acid Intervention during Pregnancy Alters DNA Methylation, Affecting Neural Target Genes through Two Distinct Mechanisms</article-title><source>Clin. Epigenet.</source><year>2022</year><volume>14</volume><fpage>63</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1186/s13148-022-01282-y</pub-id><pub-id pub-id-type="pmcid">PMC9112484</pub-id><pub-id pub-id-type="pmid">35578268</pub-id></element-citation></ref><ref id="B70-nutrients-17-02752"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McStay</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Bower</surname><given-names>C.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>D.J.</given-names></name></person-group><article-title>Maternal Folic Acid Supplementation during Pregnancy and Childhood Allergic Disease Outcomes: A Question of Timing?</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>123</elocation-id><pub-id pub-id-type="doi">10.3390/nu9020123</pub-id><pub-id pub-id-type="pmid">28208798</pub-id><pub-id pub-id-type="pmcid">PMC5331554</pub-id></element-citation></ref><ref id="B71-nutrients-17-02752"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>L.-L.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X.-D.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>C.-Y.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.-N.</given-names></name></person-group><article-title>Early Pregnancy Ultrasound Screening, Maternal Exposures and Congenital Malformation Risk collaborators Initiation and Duration of Folic Acid Supplementation in Preventing Congenital Malformations</article-title><source>BMC Med.</source><year>2023</year><volume>21</volume><fpage>292</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1186/s12916-023-03000-8</pub-id><pub-id pub-id-type="pmid">37545008</pub-id><pub-id pub-id-type="pmcid">PMC10405478</pub-id></element-citation></ref><ref id="B72-nutrients-17-02752"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherol</surname><given-names>C.C.d.S.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Lignani</surname><given-names>J.d.B.</given-names></name><name name-style="western"><surname>Salles-Costa</surname><given-names>R.</given-names></name></person-group><article-title>Regional and Social Inequalities in Food Insecurity in Brazil, 2013&#8211;2018</article-title><source>Cad. Saude Publica</source><year>2022</year><volume>38</volume><fpage>83822</fpage><lpage>83838</lpage><pub-id pub-id-type="doi">10.1590/0102-311xen083822</pub-id><pub-id pub-id-type="pmid">36629609</pub-id></element-citation></ref><ref id="B73-nutrients-17-02752"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortega</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pele</surname><given-names>A.</given-names></name></person-group><article-title>Brazil&#8217;s Unified Health System: 35 Years and Future Challenges</article-title><source>Lancet Reg. Health Am.</source><year>2023</year><volume>28</volume><fpage>100631</fpage><lpage>100632</lpage><pub-id pub-id-type="doi">10.1016/j.lana.2023.100631</pub-id><pub-id pub-id-type="pmid">38033357</pub-id><pub-id pub-id-type="pmcid">PMC10682286</pub-id></element-citation></ref><ref id="B74-nutrients-17-02752"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Massuda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>G.</given-names></name><name name-style="western"><surname>Menezes-Filho</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>de Souza Noronha</surname><given-names>K.V.M.</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>R.</given-names></name><name name-style="western"><surname>Macinko</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hone</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tasca</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Brazil&#8217;s Unified Health System: The First 30 Years and Prospects for the Future</article-title><source>Lancet</source><year>2019</year><volume>394</volume><fpage>345</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)31243-7</pub-id><pub-id pub-id-type="pmid">31303318</pub-id></element-citation></ref><ref id="B75-nutrients-17-02752"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coube</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nikoloski</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mrejen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mossialos</surname><given-names>E.</given-names></name></person-group><article-title>Persistent Inequalities in Health Care Services Utilisation in Brazil (1998&#8211;2019)</article-title><source>Int. J. Equity Health</source><year>2023</year><volume>22</volume><fpage>25</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1186/s12939-023-01828-3</pub-id><pub-id pub-id-type="pmid">36732749</pub-id><pub-id pub-id-type="pmcid">PMC9893569</pub-id></element-citation></ref><ref id="B76-nutrients-17-02752"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva J&#250;nior</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>A.D.S.</given-names></name><name name-style="western"><surname>Praxedes</surname><given-names>D.R.S.</given-names></name><name name-style="western"><surname>da Costa Paula</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>de Lima Macena</surname><given-names>M.</given-names></name><name name-style="western"><surname>de Menezes Toledo Flor&#234;ncio</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Clemente</surname><given-names>A.P.G.</given-names></name><name name-style="western"><surname>Bueno</surname><given-names>N.B.</given-names></name></person-group><article-title>Social and Racial Disparities in Food Consumption Among Brazilian College Students: A Nationwide Study</article-title><source>J. Racial Ethn. Health Disparities</source><year>2023</year><volume>10</volume><fpage>2630</fpage><lpage>2640</lpage><pub-id pub-id-type="doi">10.1007/s40615-022-01441-0</pub-id><pub-id pub-id-type="pmid">36344748</pub-id></element-citation></ref><ref id="B77-nutrients-17-02752"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mengesha</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Hidru</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Welay</surname><given-names>F.T.</given-names></name><name name-style="western"><surname>Gebremedhin</surname><given-names>T.S.</given-names></name></person-group><article-title>Effect of Maternal Education on Prenatal Adherence of Iron-Folic Acid Supplementation in Ethiopia: A Systematic Review and Meta-Analysis</article-title><source>Curr. Rev. Clin. Exp. Pharmacol.</source><year>2021</year><volume>16</volume><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.2174/1574884715999201110193353</pub-id><pub-id pub-id-type="pmid">33176661</pub-id></element-citation></ref><ref id="B78-nutrients-17-02752"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paramashanti</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Nugraheny</surname><given-names>E.</given-names></name><name name-style="western"><surname>Suparmi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Afifah</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nugraheni</surname><given-names>W.P.</given-names></name><name name-style="western"><surname>Purwatiningsih</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Oktarina</surname><given-names>O.</given-names></name><name name-style="western"><surname>Mikrajab</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Afifah</surname><given-names>E.</given-names></name><name name-style="western"><surname>Paratmanitya</surname><given-names>Y.</given-names></name></person-group><article-title>Social Determinants and Socioeconomic Inequalities in Adherence to Antenatal Iron-Folic Acid Supplementation in Urban and Rural Indonesia</article-title><source>Rural Remote Health</source><year>2024</year><volume>24</volume><fpage>8722</fpage><lpage>8733</lpage><pub-id pub-id-type="doi">10.22605/RRH8722</pub-id><pub-id pub-id-type="pmid">39522555</pub-id></element-citation></ref><ref id="B79-nutrients-17-02752"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallegos</surname><given-names>D.</given-names></name></person-group><article-title>Effects of Food and Nutrition Insecurity on Global Health</article-title><source>N. Engl. J. Med.</source><year>2025</year><volume>392</volume><fpage>686</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1056/NEJMra2406458</pub-id><pub-id pub-id-type="pmid">39938095</pub-id></element-citation></ref><ref id="B80-nutrients-17-02752"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Probst</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kilian</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lange</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>J.</given-names></name></person-group><article-title>The Role of Alcohol Use and Drinking Patterns in Socioeconomic Inequalities in Mortality: A Systematic Review</article-title><source>Lancet Public Health</source><year>2020</year><volume>5</volume><fpage>324</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(20)30052-9</pub-id><pub-id pub-id-type="pmid">32504585</pub-id></element-citation></ref><ref id="B81-nutrients-17-02752"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunes</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ara&#250;jo Castro E Silva</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Lemes</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Pezo-Valderrama</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>L.</given-names></name><name name-style="western"><surname>de Sena</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Krieger</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Catoia Varela</surname><given-names>M.</given-names></name><name name-style="western"><surname>de Azevedo</surname><given-names>L.O.</given-names></name><etal/></person-group><article-title>Admixture&#8217;s Impact on Brazilian Population Evolution and Health</article-title><source>Science</source><year>2025</year><volume>388</volume><fpage>3564</fpage><pub-id pub-id-type="doi">10.1126/science.adl3564</pub-id><pub-id pub-id-type="pmid">40373151</pub-id></element-citation></ref><ref id="B82-nutrients-17-02752"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nazki</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Sameer</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Ganaie</surname><given-names>B.A.</given-names></name></person-group><article-title>Folate: Metabolism, Genes, Polymorphisms and the Associated Diseases</article-title><source>Gene</source><year>2014</year><volume>533</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2013.09.063</pub-id><pub-id pub-id-type="pmid">24091066</pub-id></element-citation></ref><ref id="B83-nutrients-17-02752"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imani</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Mozaffari</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Sharifi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sadeghi</surname><given-names>M.</given-names></name></person-group><article-title>Polymorphism of Reduced Folate Carrier 1 (A80G) and Non-Syndromic Cleft Lip/Palate: A Systematic Review and Meta-Analysis</article-title><source>Arch. Oral Biol.</source><year>2019</year><volume>98</volume><fpage>273</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2018.12.005</pub-id><pub-id pub-id-type="pmid">30579244</pub-id></element-citation></ref><ref id="B84-nutrients-17-02752"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Binia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Contreras</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Canizales-Quinteros</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alonzo</surname><given-names>V.A.</given-names></name><name name-style="western"><surname>Tejero</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Silva-Zolezzi</surname><given-names>I.</given-names></name></person-group><article-title>Geographical and Ethnic Distribution of Single Nucleotide Polymorphisms within Genes of the Folate/Homocysteine Pathway Metabolism</article-title><source>Genes Nutr.</source><year>2014</year><volume>9</volume><fpage>421</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1007/s12263-014-0421-7</pub-id><pub-id pub-id-type="pmid">25106483</pub-id><pub-id pub-id-type="pmcid">PMC4172644</pub-id></element-citation></ref><ref id="B85-nutrients-17-02752"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chango</surname><given-names>A.</given-names></name><name name-style="western"><surname>Emery-Fillon</surname><given-names>N.</given-names></name><name name-style="western"><surname>de Courcy</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rosenblatt</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Nicolas</surname><given-names>J.-P.</given-names></name></person-group><article-title>A Polymorphism (80G-&gt;A) in the Reduced Folate Carrier Gene and Its Associations with Folate Status and Homocysteinemia</article-title><source>Mol. Genet. Metab.</source><year>2000</year><volume>70</volume><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1006/mgme.2000.3034</pub-id><pub-id pub-id-type="pmid">10993718</pub-id></element-citation></ref><ref id="B86-nutrients-17-02752"><label>86.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (ANVISA)</collab></person-group><source>Resolu&#231;&#227;o RDC N<sup>o</sup> 344, de 13 de Dezembro de 2002</source><publisher-name>ANVISA</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2002</year></element-citation></ref><ref id="B87-nutrients-17-02752"><label>87.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (ANVISA)</collab></person-group><source>Resolu&#231;&#227;o RDC N<sup>o</sup> 604, de 10 de Fevereiro de 2022</source><publisher-name>ANVISA</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2022</year></element-citation></ref><ref id="B88-nutrients-17-02752"><label>88.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (ANVISA)</collab></person-group><source>Relat&#243;rio Do Monitoramento Da Fortifica&#231;&#227;o de Farinhas de Trigo e Milho Com Ferro e &#193;cido F&#243;lico, 2020 e 2021</source><publisher-name>ANVISA</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2022</year></element-citation></ref><ref id="B89-nutrients-17-02752"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodrigues</surname><given-names>V.B.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>E.N.d.</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>L.M.P.</given-names></name></person-group><article-title>Prevented Cases of Neural Tube Defects and Cost Savings after Folic Acid Fortification of Flour in Brazil</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><fpage>281077</fpage><lpage>281092</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0281077</pub-id><pub-id pub-id-type="pmid">36812183</pub-id><pub-id pub-id-type="pmcid">PMC9946232</pub-id></element-citation></ref><ref id="B90-nutrients-17-02752"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuler-Faccini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sanseverino</surname><given-names>M.T.V.</given-names></name><name name-style="western"><surname>de Rocha Azevedo</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Moorthie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Alberg</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chowdhury</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sagoo</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Burton</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nacul</surname><given-names>L.C.</given-names></name></person-group><article-title>Health Needs Assessment for Congenital Anomalies in Middle-Income Countries: Examining the Case for Neural Tube Defects in Brazil</article-title><source>J. Community Genet.</source><year>2014</year><volume>5</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1007/s12687-013-0165-x</pub-id><pub-id pub-id-type="pmid">23990401</pub-id><pub-id pub-id-type="pmcid">PMC3955461</pub-id></element-citation></ref><ref id="B91-nutrients-17-02752"><label>91.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Minist&#233;rio da Sa&#250;de (Brasil)</collab></person-group><source>Rela&#231;&#227;o Nacional de Medicamentos Essenciais: RENAME 2024</source><publisher-name>Minist&#233;rio da Sa&#250;de (Brasil)</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2024</year></element-citation></ref><ref id="B92-nutrients-17-02752"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paniz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bertinato</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Lucena</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>De Carli</surname><given-names>E.</given-names></name><name name-style="western"><surname>Amorim</surname><given-names>P.M.d.S.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Palchetti</surname><given-names>C.Z.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Fazili</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>A Daily Dose of 5 Mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults</article-title><source>J. Nutr.</source><year>2017</year><volume>147</volume><fpage>1677</fpage><lpage>1685</lpage><pub-id pub-id-type="doi">10.3945/jn.117.247445</pub-id><pub-id pub-id-type="pmid">28724658</pub-id><pub-id pub-id-type="pmcid">PMC5712455</pub-id></element-citation></ref><ref id="B93-nutrients-17-02752"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paniz</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lucena</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Bertinato</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Louren&#231;o</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>B.C.A.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Can&#231;ado</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Blaia-D Avila</surname><given-names>V.L.N.</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>C.M.</given-names></name><etal/></person-group><article-title>Daily Supplementation with 5 Mg of Folic Acid in Brazilian Patients with Hereditary Spherocytosis</article-title><source>J. Investig. Med. Off. Publ. Am. Fed. Clin. Res.</source><year>2019</year><volume>67</volume><fpage>1110</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1136/jim-2019-001025</pub-id><pub-id pub-id-type="pmcid">PMC7065022</pub-id><pub-id pub-id-type="pmid">31076457</pub-id></element-citation></ref><ref id="B94-nutrients-17-02752"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nilson</surname><given-names>T.V.</given-names></name><name name-style="western"><surname>Amato</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Resende</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Primo</surname><given-names>W.Q.S.P.</given-names></name><name name-style="western"><surname>Nomura</surname><given-names>R.M.Y.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Opperman</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Brock</surname><given-names>M.</given-names></name><name name-style="western"><surname>Trapani Junior</surname><given-names>A.</given-names></name><name name-style="western"><surname>Damasio</surname><given-names>L.C.V.d.C.</given-names></name><etal/></person-group><article-title>Unplanned Pregnancy in Brazil: National Study in Eight University Hospitals</article-title><source>Rev. Saude Publica</source><year>2023</year><volume>57</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.11606/s1518-8787.2023057004449</pub-id><pub-id pub-id-type="pmid">37377331</pub-id><pub-id pub-id-type="pmcid">PMC10317132</pub-id></element-citation></ref><ref id="B95-nutrients-17-02752"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wehby</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Castilla</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Lopez-Camelo</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J.C.</given-names></name></person-group><article-title>Predictors of Multivitamin Use during Pregnancy in Brazil</article-title><source>Int. J. Public Health</source><year>2009</year><volume>54</volume><fpage>78</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1007/s00038-009-8103-8</pub-id><pub-id pub-id-type="pmid">19296054</pub-id><pub-id pub-id-type="pmcid">PMC2760077</pub-id></element-citation></ref><ref id="B96-nutrients-17-02752"><label>96.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cominetti</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rogero</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Peluzio</surname><given-names>M.d.C.G.</given-names></name></person-group><article-title>Vitaminas Do Complexo B e Metabolismo de Um Carbono</article-title><source>Gen&#244;mica Nutricional: Dos Fundamentos &#224; Nutri&#231;&#227;o Molecular</source><publisher-name>Editora Manole</publisher-name><publisher-loc>Barueri, Brazil</publisher-loc><year>2017</year><fpage>166</fpage><lpage>184</lpage><isbn>978-85-204-4016-2</isbn></element-citation></ref><ref id="B97-nutrients-17-02752"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidmar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gr&#382;elj</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mlinari&#269;-Ra&#353;&#269;an</surname><given-names>I.</given-names></name><name name-style="western"><surname>Ger&#353;ak</surname><given-names>K.</given-names></name><name name-style="western"><surname>Dolenc</surname><given-names>M.S.</given-names></name></person-group><article-title>Medicines Associated with Folate-Homocysteine-Methionine Pathway Disruption</article-title><source>Arch. Toxicol.</source><year>2019</year><volume>93</volume><fpage>227</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1007/s00204-018-2364-z</pub-id><pub-id pub-id-type="pmid">30499019</pub-id></element-citation></ref><ref id="B98-nutrients-17-02752"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sendeku</surname><given-names>F.W.</given-names></name><name name-style="western"><surname>Azeze</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Fenta</surname><given-names>S.L.</given-names></name></person-group><article-title>Adherence to Iron-Folic Acid Supplementation among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis</article-title><source>BMC Pregnancy Childbirth</source><year>2020</year><volume>20</volume><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1186/s12884-020-2835-0</pub-id><pub-id pub-id-type="pmid">32131751</pub-id><pub-id pub-id-type="pmcid">PMC7057669</pub-id></element-citation></ref><ref id="B99-nutrients-17-02752"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ho</surname><given-names>A.M.-C.</given-names></name><name name-style="western"><surname>Weinshilboum</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Frye</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Biernacka</surname><given-names>J.M.</given-names></name></person-group><article-title>Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What Do We Know?</article-title><source>Pharmacogenomics</source><year>2021</year><volume>22</volume><fpage>913</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.2217/pgs-2021-0041</pub-id><pub-id pub-id-type="pmid">34486896</pub-id></element-citation></ref><ref id="B100-nutrients-17-02752"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>D.L.</given-names></name></person-group><article-title>Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid&#8211;Sensitive Congenital Anomalies</article-title><source>J. Obstet. Gynaecol. Can.</source><year>2022</year><volume>44</volume><fpage>707</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.jogc.2022.04.004</pub-id><pub-id pub-id-type="pmid">35691683</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02752-f001" orientation="portrait"><label>Figure 1</label><caption><p>Timeline of folic acid supplementation, current public health recommendations, and emerging concerns. The left panel summarizes key randomized control trials (RCTs) and intervention studies from 1980 to 1992 that established the protective effect of folic acid against neural tube defects (NTDs) [<xref rid="B21-nutrients-17-02752" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-17-02752" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>,<xref rid="B26-nutrients-17-02752" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02752" ref-type="bibr">27</xref>,<xref rid="B28-nutrients-17-02752" ref-type="bibr">28</xref>]. The right side summarizes current global recommendations, including daily supplementation and food fortification policies [<xref rid="B31-nutrients-17-02752" ref-type="bibr">31</xref>,<xref rid="B33-nutrients-17-02752" ref-type="bibr">33</xref>,<xref rid="B39-nutrients-17-02752" ref-type="bibr">39</xref>]. At the bottom, ongoing concerns are illustrated, such as excessive intake, dose optimization, formulation differences, the ideal timing of supplementation, and genetic variability.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02752-g001.jpg"/></fig><fig position="float" id="nutrients-17-02752-f002" orientation="portrait"><label>Figure 2</label><caption><p>Clinical decision tree for folic acid supplementation focused on the prevention of neural tube defects. * risk factors include previous NTD-affected pregnancy and the use of antifolate drugs (e.g., anticonvulsants, methotrexate, and sulfonamides). Patients who are not planning to conceive should be using contraception. Women not of childbearing age are represented in red, women of childbearing age in blue, and women who are neither planning to conceive nor using antifolate medications in grey.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02752-g002.jpg"/></fig><fig position="float" id="nutrients-17-02752-f003" orientation="portrait"><label>Figure 3</label><caption><p>Brazilian and global challenges in folic acid supplementation. This figure summarizes the main challenges related to folic acid supplementation and possible strategies to mitigate their consequences.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02752-g003.jpg"/></fig><table-wrap position="float" id="nutrients-17-02752-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02752-t001_Table 1</object-id><label>Table 1</label><caption><p>Folic acid supplementation guidelines to prevent neural tube defects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organization</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Place</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recommendations</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U.S. Preventive Services Task Force</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">United States</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2023</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Population: all persons planning to or who could become pregnant<break/>General dose: daily 400 to 800 &#956;g<break/>High-risk dose: NA<break/>Duration: start at least 1 month prior to conception and continue through the first 2 to 3 months of pregnancy</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Society of Obstetricians and Gynaecologists of Canada (SOGC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Canada</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Population: Women aged 12&#8211;45 years who could become pregnant<break/>General dose: daily 400 &#956;g<break/>High-risk dose: daily 4000 to 5000 &#956;g *<break/>Duration: at least 2&#8211;3 months before conception, throughout the pregnancy, and for 4&#8211;6 weeks postpartum or as long as breastfeeding continues</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Australia,<break/>New Zealand</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2024</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Population: women planning to become pregnant<break/>General dose: daily 400 to 800 &#956;g<break/>High-risk dose: daily 5000 &#956;g<break/>Duration: at least four weeks before intended pregnancy and continues for the first 12 weeks of pregnancy</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Federaci&#243;n Latinoamericana de Sociedades de Obstetricia y Ginecolog&#237;a (FLASOG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Latin America</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Population: women planning to become pregnant<break/>General dose: daily 400 &#956;g<break/>High risk dose: daily 4000 &#956;g<break/>Duration: 3 months before conception and continues for the first 12 weeks of pregnancy</td></tr></tbody></table><table-wrap-foot><fn><p>* requires two separate periods of supplementation: from pre-conception to 12 weeks of gestation, and from 12 weeks of gestation until completion of breastfeeding, when the folic acid supplementation dosage reverts to the low-dosage regimen; NA (not available).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02752-t002" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02752-t002_Table 2</object-id><label>Table 2</label><caption><p>Patterns of folic acid supplementation among women based on cross-sectional studies conducted in low- and middle-income countries.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Place</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Period</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Participants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Folic Acid Supplementation</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">S&#227;o Paulo, Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">May 2004&#8211;May 2005</td><td align="center" valign="middle" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 250)</td><td align="center" valign="middle" rowspan="1" colspan="1">Periconceptional start: 77 (30.8%);<break/>start at two months of gestation:<break/>43 (17.2%) [<xref rid="B40-nutrients-17-02752" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Rio Grande do Sul, Brazil</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">April&#8211;August 2006</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Postpartum women<break/>(<italic toggle="yes">N</italic> = 1450)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Start at some point during<break/>pregnancy: 461 (31.8%);<break/>periconceptional start: 62 (4.3%) [<xref rid="B41-nutrients-17-02752" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rio Grande do Sul, Brazil </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">January 2016&#8211;January 2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Postpartum women<break/>(<italic toggle="yes">N</italic> = 765)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Start before pregnancy: 27 (3.5%),<break/>in the first trimester: 292 (38.2%),<break/>second trimester: 57 (7.4%), and<break/>third trimester: 9 (1.2%) [<xref rid="B20-nutrients-17-02752" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Golestan, Iran</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">June&#8211;November 2008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 676)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Periconceptional start: 136 (20.1%) [<xref rid="B42-nutrients-17-02752" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jos, Nigeria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">January&#8211;July 2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 543)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Periconceptional start: 26 (4.8%);<break/>among women with prior NTD-affected pregnancy, 6/15 (40%) used folic acid during the periconceptional period [<xref rid="B43-nutrients-17-02752" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Jimma, Ethiopia</td><td align="center" valign="middle" rowspan="1" colspan="1">February&#8211;March 2012</td><td align="center" valign="middle" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 339)</td><td align="center" valign="middle" rowspan="1" colspan="1">Start at some point during<break/>pregnancy: 3 (0.9%) [<xref rid="B44-nutrients-17-02752" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Anhui, China</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">October 2008&#8211;September 2009</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 4290)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Start before pregnancy: 1405 (33%);<break/>start in early pregnancy: 2797 (65.2%);<break/>periconceptional start: 2905 (67.7%);<break/>taken throughout the correct period: 690 (16.1%) [<xref rid="B45-nutrients-17-02752" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">June&#8211;December 2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnant women<break/>(<italic toggle="yes">N</italic> = 428)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Start before pregnancy: 198 (46.3%) [<xref rid="B46-nutrients-17-02752" ref-type="bibr">46</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Data include study location, period, participant type, sample size, and timing of folic acid supplementation initiation. Values are presented as absolute numbers and percentages based on each study&#8217;s sample. References are indicated in brackets and correspond to the numbered bibliography.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02752-t003" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02752-t003_Table 3</object-id><label>Table 3</label><caption><p>Benefits and potential risks associated with excessive folate intake.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Benefits</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Potential Risks</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention of neural tube defect recurrence [<xref rid="B23-nutrients-17-02752" ref-type="bibr">23</xref>]<break/><break/>Congenital heart defects prevention [<xref rid="B54-nutrients-17-02752" ref-type="bibr">54</xref>]<break/><break/>Protection against preterm birth and low birth weight [<xref rid="B55-nutrients-17-02752" ref-type="bibr">55</xref>]<break/><break/>Enhanced communication skills in children [<xref rid="B55-nutrients-17-02752" ref-type="bibr">55</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased cancer risk in the presence of preneoplastic lesions [<xref rid="B56-nutrients-17-02752" ref-type="bibr">56</xref>]<break/><break/>Mask B12 deficiency anemia [<xref rid="B57-nutrients-17-02752" ref-type="bibr">57</xref>]<break/><break/>Gestational diabetes mellitus [<xref rid="B49-nutrients-17-02752" ref-type="bibr">49</xref>]<break/><break/>Low birth weight [<xref rid="B58-nutrients-17-02752" ref-type="bibr">58</xref>]<break/><break/>Insulin resistance in children [<xref rid="B50-nutrients-17-02752" ref-type="bibr">50</xref>]<break/><break/>Impaired neurocognitive development in children [<xref rid="B59-nutrients-17-02752" ref-type="bibr">59</xref>]<break/><break/>Increased risk of childhood asthma [<xref rid="B60-nutrients-17-02752" ref-type="bibr">60</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>This table summarizes the reported benefits and potential adverse outcomes associated with excessive folate intake. References are indicated in brackets and correspond to the numbered bibliography.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>